id	sid	tid	token	lemma	pos
cord-311353-ozqfsuh8	1	1	key	key	JJ
cord-311353-ozqfsuh8	2	1	:	:	:
cord-311353-ozqfsuh8	2	2	cord-311353-ozqfsuh8	cord-311353-ozqfsuh8	NN
cord-311353-ozqfsuh8	2	3	authors	author	NNS
cord-311353-ozqfsuh8	2	4	:	:	:
cord-311353-ozqfsuh8	2	5	Sun	Sun	NNP
cord-311353-ozqfsuh8	2	6	,	,	,
cord-311353-ozqfsuh8	2	7	Chun	Chun	NNP
cord-311353-ozqfsuh8	2	8	-	-	HYPH
cord-311353-ozqfsuh8	2	9	Yang	Yang	NNP
cord-311353-ozqfsuh8	2	10	;	;	:
cord-311353-ozqfsuh8	2	11	Sun	Sun	NNP
cord-311353-ozqfsuh8	2	12	,	,	,
cord-311353-ozqfsuh8	2	13	Ya	Ya	NNP
cord-311353-ozqfsuh8	2	14	-	-	HYPH
cord-311353-ozqfsuh8	2	15	Lei	Lei	NNP
cord-311353-ozqfsuh8	2	16	;	;	:
cord-311353-ozqfsuh8	2	17	Li	Li	NNP
cord-311353-ozqfsuh8	2	18	,	,	,
cord-311353-ozqfsuh8	2	19	Xin	Xin	NNP
cord-311353-ozqfsuh8	2	20	-	-	HYPH
cord-311353-ozqfsuh8	2	21	Min	Min	NNP
cord-311353-ozqfsuh8	2	22	title	title	NN
cord-311353-ozqfsuh8	2	23	:	:	:
cord-311353-ozqfsuh8	3	1	The	the	DT
cord-311353-ozqfsuh8	3	2	role	role	NN
cord-311353-ozqfsuh8	3	3	of	of	IN
cord-311353-ozqfsuh8	3	4	Chinese	chinese	JJ
cord-311353-ozqfsuh8	3	5	medicine	medicine	NN
cord-311353-ozqfsuh8	3	6	in	in	IN
cord-311353-ozqfsuh8	3	7	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	3	8	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	3	9	:	:	:
cord-311353-ozqfsuh8	3	10	A	a	DT
cord-311353-ozqfsuh8	3	11	systematic	systematic	JJ
cord-311353-ozqfsuh8	3	12	review	review	NN
cord-311353-ozqfsuh8	3	13	and	and	CC
cord-311353-ozqfsuh8	3	14	meta	meta	NN
cord-311353-ozqfsuh8	3	15	-	-	HYPH
cord-311353-ozqfsuh8	3	16	analysis	analysis	NN
cord-311353-ozqfsuh8	3	17	date	date	NN
cord-311353-ozqfsuh8	3	18	:	:	:
cord-311353-ozqfsuh8	3	19	2020	2020	CD
cord-311353-ozqfsuh8	3	20	-	-	HYPH
cord-311353-ozqfsuh8	3	21	07	07	CD
cord-311353-ozqfsuh8	3	22	-	-	HYPH
cord-311353-ozqfsuh8	3	23	08	08	CD
cord-311353-ozqfsuh8	3	24	journal	journal	NN
cord-311353-ozqfsuh8	3	25	:	:	:
cord-311353-ozqfsuh8	4	1	Am	be	VBP
cord-311353-ozqfsuh8	4	2	J	J	NNP
cord-311353-ozqfsuh8	4	3	Emerg	Emerg	NNP
cord-311353-ozqfsuh8	4	4	Med	Med	NNP
cord-311353-ozqfsuh8	4	5	DOI	DOI	NNP
cord-311353-ozqfsuh8	4	6	:	:	:
cord-311353-ozqfsuh8	4	7	10.1016	10.1016	CD
cord-311353-ozqfsuh8	4	8	/	/	SYM
cord-311353-ozqfsuh8	4	9	j.ajem.2020.06.069	j.ajem.2020.06.069	CD
cord-311353-ozqfsuh8	4	10	sha	sha	NNP
cord-311353-ozqfsuh8	4	11	:	:	:
cord-311353-ozqfsuh8	5	1	b0a145a05429ef971931f6758145f685df1ed74f	b0a145a05429ef971931f6758145f685df1ed74f	NNP
cord-311353-ozqfsuh8	5	2	doc_id	doc_id	CD
cord-311353-ozqfsuh8	5	3	:	:	:
cord-311353-ozqfsuh8	5	4	311353	311353	CD
cord-311353-ozqfsuh8	5	5	cord_uid	cord_uid	NN
cord-311353-ozqfsuh8	5	6	:	:	:
cord-311353-ozqfsuh8	6	1	ozqfsuh8	ozqfsuh8	NN
cord-311353-ozqfsuh8	6	2	INTRODUCTION	introduction	NN
cord-311353-ozqfsuh8	6	3	:	:	:
cord-311353-ozqfsuh8	6	4	Chinese	chinese	JJ
cord-311353-ozqfsuh8	6	5	medicine	medicine	NN
cord-311353-ozqfsuh8	6	6	(	(	-LRB-
cord-311353-ozqfsuh8	6	7	CM	CM	NNP
cord-311353-ozqfsuh8	6	8	)	)	-RRB-
cord-311353-ozqfsuh8	6	9	has	have	VBZ
cord-311353-ozqfsuh8	6	10	been	be	VBN
cord-311353-ozqfsuh8	6	11	used	use	VBN
cord-311353-ozqfsuh8	6	12	to	to	TO
cord-311353-ozqfsuh8	6	13	treat	treat	VB
cord-311353-ozqfsuh8	6	14	Novel	Novel	NNP
cord-311353-ozqfsuh8	6	15	Coronavirus	Coronavirus	NNP
cord-311353-ozqfsuh8	6	16	2019	2019	CD
cord-311353-ozqfsuh8	6	17	(	(	-LRB-
cord-311353-ozqfsuh8	6	18	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	6	19	)	)	-RRB-
cord-311353-ozqfsuh8	6	20	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	6	21	in	in	IN
cord-311353-ozqfsuh8	6	22	China	China	NNP
cord-311353-ozqfsuh8	6	23	.	.	.
cord-311353-ozqfsuh8	7	1	This	this	DT
cord-311353-ozqfsuh8	7	2	meta	meta	NN
cord-311353-ozqfsuh8	7	3	-	-	HYPH
cord-311353-ozqfsuh8	7	4	analysis	analysis	NN
cord-311353-ozqfsuh8	7	5	was	be	VBD
cord-311353-ozqfsuh8	7	6	conducted	conduct	VBN
cord-311353-ozqfsuh8	7	7	to	to	TO
cord-311353-ozqfsuh8	7	8	evaluate	evaluate	VB
cord-311353-ozqfsuh8	7	9	the	the	DT
cord-311353-ozqfsuh8	7	10	clinical	clinical	JJ
cord-311353-ozqfsuh8	7	11	efficacy	efficacy	NN
cord-311353-ozqfsuh8	7	12	and	and	CC
cord-311353-ozqfsuh8	7	13	safety	safety	NN
cord-311353-ozqfsuh8	7	14	of	of	IN
cord-311353-ozqfsuh8	7	15	CM	cm	NN
cord-311353-ozqfsuh8	7	16	in	in	IN
cord-311353-ozqfsuh8	7	17	the	the	DT
cord-311353-ozqfsuh8	7	18	treatment	treatment	NN
cord-311353-ozqfsuh8	7	19	of	of	IN
cord-311353-ozqfsuh8	7	20	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	7	21	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	7	22	.	.	.
cord-311353-ozqfsuh8	8	1	METHODS	methods	NN
cord-311353-ozqfsuh8	8	2	:	:	:
cord-311353-ozqfsuh8	9	1	Randomized	randomized	JJ
cord-311353-ozqfsuh8	9	2	controlled	control	VBN
cord-311353-ozqfsuh8	9	3	trials	trial	NNS
cord-311353-ozqfsuh8	9	4	(	(	-LRB-
cord-311353-ozqfsuh8	9	5	RCTs	RCTs	NNP
cord-311353-ozqfsuh8	9	6	)	)	-RRB-
cord-311353-ozqfsuh8	9	7	involving	involve	VBG
cord-311353-ozqfsuh8	9	8	CM	cm	NN
cord-311353-ozqfsuh8	9	9	in	in	IN
cord-311353-ozqfsuh8	9	10	the	the	DT
cord-311353-ozqfsuh8	9	11	treatment	treatment	NN
cord-311353-ozqfsuh8	9	12	of	of	IN
cord-311353-ozqfsuh8	9	13	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	9	14	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	9	15	were	be	VBD
cord-311353-ozqfsuh8	9	16	identified	identify	VBN
cord-311353-ozqfsuh8	9	17	from	from	IN
cord-311353-ozqfsuh8	9	18	Cochrane	Cochrane	NNP
cord-311353-ozqfsuh8	9	19	Central	Central	NNP
cord-311353-ozqfsuh8	9	20	Register	Register	NNP
cord-311353-ozqfsuh8	9	21	of	of	IN
cord-311353-ozqfsuh8	9	22	Controlled	Controlled	NNP
cord-311353-ozqfsuh8	9	23	Trials	Trials	NNPS
cord-311353-ozqfsuh8	9	24	,	,	,
cord-311353-ozqfsuh8	9	25	PubMed	PubMed	NNP
cord-311353-ozqfsuh8	9	26	,	,	,
cord-311353-ozqfsuh8	9	27	EMBASE	EMBASE	NNP
cord-311353-ozqfsuh8	9	28	,	,	,
cord-311353-ozqfsuh8	9	29	Chinese	Chinese	NNP
cord-311353-ozqfsuh8	9	30	National	National	NNP
cord-311353-ozqfsuh8	9	31	Knowledge	Knowledge	NNP
cord-311353-ozqfsuh8	9	32	Infrastructure	Infrastructure	NNP
cord-311353-ozqfsuh8	9	33	,	,	,
cord-311353-ozqfsuh8	9	34	Chinese	Chinese	NNP
cord-311353-ozqfsuh8	9	35	Biomedical	Biomedical	NNP
cord-311353-ozqfsuh8	9	36	Database	Database	NNP
cord-311353-ozqfsuh8	9	37	,	,	,
cord-311353-ozqfsuh8	9	38	Wanfang	Wanfang	NNP
cord-311353-ozqfsuh8	9	39	Database	Database	NNP
cord-311353-ozqfsuh8	9	40	and	and	CC
cord-311353-ozqfsuh8	9	41	VIP	VIP	NNP
cord-311353-ozqfsuh8	9	42	Information	information	NN
cord-311353-ozqfsuh8	9	43	Database	Database	NNP
cord-311353-ozqfsuh8	9	44	.	.	.
cord-311353-ozqfsuh8	10	1	The	the	DT
cord-311353-ozqfsuh8	10	2	methodological	methodological	JJ
cord-311353-ozqfsuh8	10	3	quality	quality	NN
cord-311353-ozqfsuh8	10	4	of	of	IN
cord-311353-ozqfsuh8	10	5	trials	trial	NNS
cord-311353-ozqfsuh8	10	6	was	be	VBD
cord-311353-ozqfsuh8	10	7	evaluated	evaluate	VBN
cord-311353-ozqfsuh8	10	8	with	with	IN
cord-311353-ozqfsuh8	10	9	Cochrane	Cochrane	NNP
cord-311353-ozqfsuh8	10	10	Hanadbook	Hanadbook	NNP
cord-311353-ozqfsuh8	10	11	criteria	criterion	NNS
cord-311353-ozqfsuh8	10	12	,	,	,
cord-311353-ozqfsuh8	10	13	and	and	CC
cord-311353-ozqfsuh8	10	14	the	the	DT
cord-311353-ozqfsuh8	10	15	Cochrane	Cochrane	NNP
cord-311353-ozqfsuh8	10	16	Collaboration	Collaboration	NNP
cord-311353-ozqfsuh8	10	17	's	's	POS
cord-311353-ozqfsuh8	10	18	Review	Review	NNP
cord-311353-ozqfsuh8	10	19	Manager	Manager	NNP
cord-311353-ozqfsuh8	10	20	5.3	5.3	CD
cord-311353-ozqfsuh8	10	21	software	software	NN
cord-311353-ozqfsuh8	10	22	was	be	VBD
cord-311353-ozqfsuh8	10	23	used	use	VBN
cord-311353-ozqfsuh8	10	24	for	for	IN
cord-311353-ozqfsuh8	10	25	meta	meta	NNP
cord-311353-ozqfsuh8	10	26	-	-	HYPH
cord-311353-ozqfsuh8	10	27	analysis	analysis	NN
cord-311353-ozqfsuh8	10	28	.	.	.
cord-311353-ozqfsuh8	11	1	RESULTS	result	NNS
cord-311353-ozqfsuh8	11	2	:	:	:
cord-311353-ozqfsuh8	12	1	A	a	DT
cord-311353-ozqfsuh8	12	2	total	total	NN
cord-311353-ozqfsuh8	12	3	of	of	IN
cord-311353-ozqfsuh8	12	4	7	7	CD
cord-311353-ozqfsuh8	12	5	valid	valid	JJ
cord-311353-ozqfsuh8	12	6	studies	study	NNS
cord-311353-ozqfsuh8	12	7	involving	involve	VBG
cord-311353-ozqfsuh8	12	8	681	681	CD
cord-311353-ozqfsuh8	12	9	patients	patient	NNS
cord-311353-ozqfsuh8	12	10	were	be	VBD
cord-311353-ozqfsuh8	12	11	included	include	VBN
cord-311353-ozqfsuh8	12	12	.	.	.
cord-311353-ozqfsuh8	13	1	The	the	DT
cord-311353-ozqfsuh8	13	2	meta	meta	JJ
cord-311353-ozqfsuh8	13	3	-	-	HYPH
cord-311353-ozqfsuh8	13	4	analysis	analysis	NN
cord-311353-ozqfsuh8	13	5	exhibited	exhibit	VBN
cord-311353-ozqfsuh8	13	6	in	in	IN
cord-311353-ozqfsuh8	13	7	comparison	comparison	NN
cord-311353-ozqfsuh8	13	8	to	to	IN
cord-311353-ozqfsuh8	13	9	conventional	conventional	JJ
cord-311353-ozqfsuh8	13	10	treatment	treatment	NN
cord-311353-ozqfsuh8	13	11	,	,	,
cord-311353-ozqfsuh8	13	12	CM	CM	NNP
cord-311353-ozqfsuh8	13	13	combined	combine	VBN
cord-311353-ozqfsuh8	13	14	with	with	IN
cord-311353-ozqfsuh8	13	15	conventional	conventional	JJ
cord-311353-ozqfsuh8	13	16	treatment	treatment	NN
cord-311353-ozqfsuh8	13	17	significantly	significantly	RB
cord-311353-ozqfsuh8	13	18	improved	improve	VBD
cord-311353-ozqfsuh8	13	19	clinical	clinical	JJ
cord-311353-ozqfsuh8	13	20	efficacy	efficacy	NN
cord-311353-ozqfsuh8	13	21	(	(	-LRB-
cord-311353-ozqfsuh8	13	22	RR	rr	NN
cord-311353-ozqfsuh8	13	23	=	=	SYM
cord-311353-ozqfsuh8	13	24	1.21	1.21	CD
cord-311353-ozqfsuh8	13	25	,	,	,
cord-311353-ozqfsuh8	13	26	95	95	CD
cord-311353-ozqfsuh8	13	27	%	%	NN
cord-311353-ozqfsuh8	13	28	CI	ci	NN
cord-311353-ozqfsuh8	13	29	[	[	-LRB-
cord-311353-ozqfsuh8	13	30	1.08,1.36	1.08,1.36	CD
cord-311353-ozqfsuh8	13	31	]	]	-RRB-
cord-311353-ozqfsuh8	13	32	)	)	-RRB-
cord-311353-ozqfsuh8	13	33	,	,	,
cord-311353-ozqfsuh8	13	34	and	and	CC
cord-311353-ozqfsuh8	13	35	significantly	significantly	RB
cord-311353-ozqfsuh8	13	36	increased	increase	VBD
cord-311353-ozqfsuh8	13	37	viral	viral	JJ
cord-311353-ozqfsuh8	13	38	nucleic	nucleic	JJ
cord-311353-ozqfsuh8	13	39	acid	acid	NN
cord-311353-ozqfsuh8	13	40	negative	negative	JJ
cord-311353-ozqfsuh8	13	41	conversion	conversion	NN
cord-311353-ozqfsuh8	13	42	rate	rate	NN
cord-311353-ozqfsuh8	13	43	(	(	-LRB-
cord-311353-ozqfsuh8	13	44	RR	rr	NN
cord-311353-ozqfsuh8	13	45	=	=	SYM
cord-311353-ozqfsuh8	13	46	1.49	1.49	CD
cord-311353-ozqfsuh8	13	47	,	,	,
cord-311353-ozqfsuh8	13	48	95	95	CD
cord-311353-ozqfsuh8	13	49	%	%	NN
cord-311353-ozqfsuh8	13	50	CI	CI	NNP
cord-311353-ozqfsuh8	13	51	[	[	-LRB-
cord-311353-ozqfsuh8	13	52	1.13,1.97	1.13,1.97	CD
cord-311353-ozqfsuh8	13	53	]	]	-RRB-
cord-311353-ozqfsuh8	13	54	)	)	-RRB-
cord-311353-ozqfsuh8	13	55	.	.	.
cord-311353-ozqfsuh8	14	1	CM	CM	NNP
cord-311353-ozqfsuh8	14	2	also	also	RB
cord-311353-ozqfsuh8	14	3	prominently	prominently	RB
cord-311353-ozqfsuh8	14	4	reduced	reduce	VBN
cord-311353-ozqfsuh8	14	5	pulmonary	pulmonary	JJ
cord-311353-ozqfsuh8	14	6	inflammation	inflammation	NN
cord-311353-ozqfsuh8	14	7	(	(	-LRB-
cord-311353-ozqfsuh8	14	8	RR	rr	NN
cord-311353-ozqfsuh8	14	9	=	=	SYM
cord-311353-ozqfsuh8	14	10	1.27	1.27	CD
cord-311353-ozqfsuh8	15	1	,	,	,
cord-311353-ozqfsuh8	15	2	95	95	CD
cord-311353-ozqfsuh8	15	3	%	%	NN
cord-311353-ozqfsuh8	15	4	CI	CI	NNP
cord-311353-ozqfsuh8	15	5	[	[	-LRB-
cord-311353-ozqfsuh8	15	6	1.12,1.44	1.12,1.44	CD
cord-311353-ozqfsuh8	15	7	]	]	-RRB-
cord-311353-ozqfsuh8	15	8	)	)	-RRB-
cord-311353-ozqfsuh8	15	9	,	,	,
cord-311353-ozqfsuh8	15	10	and	and	CC
cord-311353-ozqfsuh8	15	11	improved	improve	VBD
cord-311353-ozqfsuh8	15	12	host	host	NN
cord-311353-ozqfsuh8	15	13	immune	immune	JJ
cord-311353-ozqfsuh8	15	14	function	function	NN
cord-311353-ozqfsuh8	15	15	(	(	-LRB-
cord-311353-ozqfsuh8	15	16	WBC	WBC	NNP
cord-311353-ozqfsuh8	15	17	,	,	,
cord-311353-ozqfsuh8	15	18	MD	MD	NNP
cord-311353-ozqfsuh8	15	19	=	=	SYM
cord-311353-ozqfsuh8	15	20	0.92	0.92	CD
cord-311353-ozqfsuh8	15	21	,	,	,
cord-311353-ozqfsuh8	15	22	95	95	CD
cord-311353-ozqfsuh8	15	23	%	%	NN
cord-311353-ozqfsuh8	15	24	CI	CI	NNP
cord-311353-ozqfsuh8	15	25	[	[	-LRB-
cord-311353-ozqfsuh8	15	26	0.07,1.76	0.07,1.76	CD
cord-311353-ozqfsuh8	15	27	]	]	-RRB-
cord-311353-ozqfsuh8	15	28	;	;	:
cord-311353-ozqfsuh8	15	29	LYM	LYM	NNP
cord-311353-ozqfsuh8	15	30	,	,	,
cord-311353-ozqfsuh8	15	31	MD	MD	NNP
cord-311353-ozqfsuh8	15	32	=	=	SYM
cord-311353-ozqfsuh8	15	33	0.33	0.33	CD
cord-311353-ozqfsuh8	15	34	,	,	,
cord-311353-ozqfsuh8	15	35	95	95	CD
cord-311353-ozqfsuh8	15	36	%	%	NN
cord-311353-ozqfsuh8	15	37	CI	ci	NN
cord-311353-ozqfsuh8	15	38	[	[	-LRB-
cord-311353-ozqfsuh8	15	39	0.08,0.57	0.08,0.57	CD
cord-311353-ozqfsuh8	15	40	]	]	-RRB-
cord-311353-ozqfsuh8	15	41	;	;	:
cord-311353-ozqfsuh8	16	1	LYM%	LYM%	NNP
cord-311353-ozqfsuh8	16	2	,	,	,
cord-311353-ozqfsuh8	16	3	MD	MD	NNP
cord-311353-ozqfsuh8	16	4	=	=	SYM
cord-311353-ozqfsuh8	16	5	2.90	2.90	CD
cord-311353-ozqfsuh8	16	6	,	,	,
cord-311353-ozqfsuh8	16	7	95	95	CD
cord-311353-ozqfsuh8	16	8	%	%	NN
cord-311353-ozqfsuh8	16	9	CI	CI	NNP
cord-311353-ozqfsuh8	16	10	[	[	-LRB-
cord-311353-ozqfsuh8	16	11	2.09,3.71	2.09,3.71	CD
cord-311353-ozqfsuh8	16	12	]	]	-RRB-
cord-311353-ozqfsuh8	16	13	;	;	:
cord-311353-ozqfsuh8	16	14	CRP	CRP	NNP
cord-311353-ozqfsuh8	16	15	,	,	,
cord-311353-ozqfsuh8	16	16	MD	MD	NNP
cord-311353-ozqfsuh8	16	17	=	=	SYM
cord-311353-ozqfsuh8	16	18	−12.66	−12.66	NNP
cord-311353-ozqfsuh8	16	19	,	,	,
cord-311353-ozqfsuh8	16	20	95	95	CD
cord-311353-ozqfsuh8	16	21	%	%	NN
cord-311353-ozqfsuh8	16	22	CI	CI	NNP
cord-311353-ozqfsuh8	16	23	[	[	-LRB-
cord-311353-ozqfsuh8	16	24	−24.40	−24.40	XX
cord-311353-ozqfsuh8	16	25	,	,	,
cord-311353-ozqfsuh8	16	26	−0.92	−0.92	NNP
cord-311353-ozqfsuh8	16	27	]	]	-RRB-
cord-311353-ozqfsuh8	16	28	)	)	-RRB-
cord-311353-ozqfsuh8	16	29	.	.	.
cord-311353-ozqfsuh8	17	1	Meanwhile	meanwhile	RB
cord-311353-ozqfsuh8	17	2	,	,	,
cord-311353-ozqfsuh8	17	3	CM	CM	NNP
cord-311353-ozqfsuh8	17	4	did	do	VBD
cord-311353-ozqfsuh8	17	5	not	not	RB
cord-311353-ozqfsuh8	17	6	increase	increase	VB
cord-311353-ozqfsuh8	17	7	the	the	DT
cord-311353-ozqfsuh8	17	8	incidence	incidence	NN
cord-311353-ozqfsuh8	17	9	of	of	IN
cord-311353-ozqfsuh8	17	10	adverse	adverse	JJ
cord-311353-ozqfsuh8	17	11	reactions	reaction	NNS
cord-311353-ozqfsuh8	17	12	(	(	-LRB-
cord-311353-ozqfsuh8	17	13	RR	rr	NN
cord-311353-ozqfsuh8	17	14	=	=	SYM
cord-311353-ozqfsuh8	17	15	1.17	1.17	CD
cord-311353-ozqfsuh8	17	16	,	,	,
cord-311353-ozqfsuh8	17	17	95	95	CD
cord-311353-ozqfsuh8	17	18	%	%	NN
cord-311353-ozqfsuh8	17	19	CI	ci	NN
cord-311353-ozqfsuh8	17	20	[	[	-LRB-
cord-311353-ozqfsuh8	17	21	0.39,3.52	0.39,3.52	NFP
cord-311353-ozqfsuh8	17	22	]	]	-RRB-
cord-311353-ozqfsuh8	17	23	)	)	-RRB-
cord-311353-ozqfsuh8	17	24	.	.	.
cord-311353-ozqfsuh8	18	1	CONCLUSION	conclusion	NN
cord-311353-ozqfsuh8	18	2	:	:	:
cord-311353-ozqfsuh8	19	1	According	accord	VBG
cord-311353-ozqfsuh8	19	2	to	to	IN
cord-311353-ozqfsuh8	19	3	the	the	DT
cord-311353-ozqfsuh8	19	4	allocated	allocate	VBN
cord-311353-ozqfsuh8	19	5	data	datum	NNS
cord-311353-ozqfsuh8	19	6	,	,	,
cord-311353-ozqfsuh8	19	7	CM	CM	NNP
cord-311353-ozqfsuh8	19	8	has	have	VBZ
cord-311353-ozqfsuh8	19	9	demonstrated	demonstrate	VBN
cord-311353-ozqfsuh8	19	10	clinical	clinical	JJ
cord-311353-ozqfsuh8	19	11	efficacy	efficacy	NN
cord-311353-ozqfsuh8	19	12	and	and	CC
cord-311353-ozqfsuh8	19	13	safety	safety	NN
cord-311353-ozqfsuh8	19	14	on	on	IN
cord-311353-ozqfsuh8	19	15	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	19	16	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	19	17	,	,	,
cord-311353-ozqfsuh8	19	18	which	which	WDT
cord-311353-ozqfsuh8	19	19	need	need	VBP
cord-311353-ozqfsuh8	19	20	to	to	TO
cord-311353-ozqfsuh8	19	21	be	be	VB
cord-311353-ozqfsuh8	19	22	confirmed	confirm	VBN
cord-311353-ozqfsuh8	19	23	by	by	IN
cord-311353-ozqfsuh8	19	24	high	high	JJ
cord-311353-ozqfsuh8	19	25	quality	quality	NN
cord-311353-ozqfsuh8	19	26	,	,	,
cord-311353-ozqfsuh8	19	27	multiple	multiple	JJ
cord-311353-ozqfsuh8	19	28	-	-	HYPH
cord-311353-ozqfsuh8	19	29	center	center	NN
cord-311353-ozqfsuh8	19	30	,	,	,
cord-311353-ozqfsuh8	19	31	large	large	JJ
cord-311353-ozqfsuh8	19	32	sample	sample	NN
cord-311353-ozqfsuh8	19	33	randomized	randomize	VBN
cord-311353-ozqfsuh8	19	34	controlled	control	VBN
cord-311353-ozqfsuh8	19	35	trials	trial	NNS
cord-311353-ozqfsuh8	19	36	.	.	.
cord-311353-ozqfsuh8	20	1	Novel	novel	JJ
cord-311353-ozqfsuh8	20	2	Coronavirus	Coronavirus	NNP
cord-311353-ozqfsuh8	20	3	disease	disease	NN
cord-311353-ozqfsuh8	20	4	2019	2019	CD
cord-311353-ozqfsuh8	20	5	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	20	6	is	be	VBZ
cord-311353-ozqfsuh8	20	7	caused	cause	VBN
cord-311353-ozqfsuh8	20	8	by	by	IN
cord-311353-ozqfsuh8	20	9	severe	severe	JJ
cord-311353-ozqfsuh8	20	10	acute	acute	JJ
cord-311353-ozqfsuh8	20	11	respiratory	respiratory	JJ
cord-311353-ozqfsuh8	20	12	syndrome	syndrome	NN
cord-311353-ozqfsuh8	20	13	coronavirus	coronavirus	NN
cord-311353-ozqfsuh8	20	14	2	2	CD
cord-311353-ozqfsuh8	21	1	(	(	-LRB-
cord-311353-ozqfsuh8	21	2	SARS	SARS	NNP
cord-311353-ozqfsuh8	21	3	-	-	HYPH
cord-311353-ozqfsuh8	21	4	CoV-2	CoV-2	NNP
cord-311353-ozqfsuh8	21	5	)	)	-RRB-
cord-311353-ozqfsuh8	21	6	,	,	,
cord-311353-ozqfsuh8	21	7	which	which	WDT
cord-311353-ozqfsuh8	21	8	firstly	firstly	RB
cord-311353-ozqfsuh8	21	9	appeared	appear	VBD
cord-311353-ozqfsuh8	21	10	in	in	IN
cord-311353-ozqfsuh8	21	11	Wuhan	Wuhan	NNP
cord-311353-ozqfsuh8	21	12	,	,	,
cord-311353-ozqfsuh8	21	13	China	China	NNP
cord-311353-ozqfsuh8	21	14	[	[	-LRB-
cord-311353-ozqfsuh8	21	15	1	1	CD
cord-311353-ozqfsuh8	21	16	]	]	-RRB-
cord-311353-ozqfsuh8	21	17	[	[	-LRB-
cord-311353-ozqfsuh8	21	18	2	2	CD
cord-311353-ozqfsuh8	21	19	]	]	-RRB-
cord-311353-ozqfsuh8	21	20	.	.	.
cord-311353-ozqfsuh8	22	1	It	-PRON-	PRP
cord-311353-ozqfsuh8	22	2	is	be	VBZ
cord-311353-ozqfsuh8	22	3	highly	highly	RB
cord-311353-ozqfsuh8	22	4	infectious	infectious	JJ
cord-311353-ozqfsuh8	22	5	and	and	CC
cord-311353-ozqfsuh8	22	6	spreads	spread	VBZ
cord-311353-ozqfsuh8	22	7	through	through	IN
cord-311353-ozqfsuh8	22	8	respiratory	respiratory	JJ
cord-311353-ozqfsuh8	22	9	droplets	droplet	NNS
cord-311353-ozqfsuh8	22	10	and	and	CC
cord-311353-ozqfsuh8	22	11	contact	contact	NN
cord-311353-ozqfsuh8	22	12	[	[	-LRB-
cord-311353-ozqfsuh8	22	13	3	3	CD
cord-311353-ozqfsuh8	22	14	]	]	-RRB-
cord-311353-ozqfsuh8	22	15	.	.	.
cord-311353-ozqfsuh8	23	1	It	-PRON-	PRP
cord-311353-ozqfsuh8	23	2	is	be	VBZ
cord-311353-ozqfsuh8	23	3	characterized	characterize	VBN
cord-311353-ozqfsuh8	23	4	by	by	IN
cord-311353-ozqfsuh8	23	5	acute	acute	JJ
cord-311353-ozqfsuh8	23	6	onset	onset	NN
cord-311353-ozqfsuh8	23	7	,	,	,
cord-311353-ozqfsuh8	23	8	severe	severe	JJ
cord-311353-ozqfsuh8	23	9	symptoms	symptom	NNS
cord-311353-ozqfsuh8	23	10	,	,	,
cord-311353-ozqfsuh8	23	11	such	such	JJ
cord-311353-ozqfsuh8	23	12	as	as	IN
cord-311353-ozqfsuh8	23	13	dyspnea	dyspnea	NN
cord-311353-ozqfsuh8	23	14	and	and	CC
cord-311353-ozqfsuh8	23	15	multi	multi	JJ
cord-311353-ozqfsuh8	23	16	-	-	JJ
cord-311353-ozqfsuh8	23	17	organ	organ	JJ
cord-311353-ozqfsuh8	23	18	dysfunction	dysfunction	NN
cord-311353-ozqfsuh8	23	19	[	[	-LRB-
cord-311353-ozqfsuh8	23	20	4	4	CD
cord-311353-ozqfsuh8	23	21	]	]	-RRB-
cord-311353-ozqfsuh8	23	22	.	.	.
cord-311353-ozqfsuh8	24	1	The	the	DT
cord-311353-ozqfsuh8	24	2	World	World	NNP
cord-311353-ozqfsuh8	24	3	Health	Health	NNP
cord-311353-ozqfsuh8	24	4	Organization	Organization	NNP
cord-311353-ozqfsuh8	24	5	listed	list	VBD
cord-311353-ozqfsuh8	24	6	this	this	DT
cord-311353-ozqfsuh8	24	7	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	24	8	epidemic	epidemic	NN
cord-311353-ozqfsuh8	24	9	of	of	IN
cord-311353-ozqfsuh8	24	10	Wuhan	Wuhan	NNP
cord-311353-ozqfsuh8	24	11	,	,	,
cord-311353-ozqfsuh8	24	12	China	China	NNP
cord-311353-ozqfsuh8	24	13	,	,	,
cord-311353-ozqfsuh8	24	14	as	as	IN
cord-311353-ozqfsuh8	24	15	a	a	DT
cord-311353-ozqfsuh8	24	16	public	public	JJ
cord-311353-ozqfsuh8	24	17	health	health	NN
cord-311353-ozqfsuh8	24	18	emergency	emergency	NN
cord-311353-ozqfsuh8	24	19	of	of	IN
cord-311353-ozqfsuh8	24	20	international	international	JJ
cord-311353-ozqfsuh8	24	21	concern	concern	NN
cord-311353-ozqfsuh8	24	22	[	[	-LRB-
cord-311353-ozqfsuh8	24	23	5	5	CD
cord-311353-ozqfsuh8	24	24	]	]	-RRB-
cord-311353-ozqfsuh8	24	25	.	.	.
cord-311353-ozqfsuh8	25	1	The	the	DT
cord-311353-ozqfsuh8	25	2	world	world	NN
cord-311353-ozqfsuh8	25	3	is	be	VBZ
cord-311353-ozqfsuh8	25	4	now	now	RB
cord-311353-ozqfsuh8	25	5	facing	face	VBG
cord-311353-ozqfsuh8	25	6	a	a	DT
cord-311353-ozqfsuh8	25	7	pandemic	pandemic	NN
cord-311353-ozqfsuh8	25	8	of	of	IN
cord-311353-ozqfsuh8	25	9	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	25	10	,	,	,
cord-311353-ozqfsuh8	25	11	for	for	IN
cord-311353-ozqfsuh8	25	12	which	which	WDT
cord-311353-ozqfsuh8	25	13	no	no	DT
cord-311353-ozqfsuh8	25	14	proven	prove	VBN
cord-311353-ozqfsuh8	25	15	specific	specific	JJ
cord-311353-ozqfsuh8	25	16	therapies	therapy	NNS
cord-311353-ozqfsuh8	25	17	are	be	VBP
cord-311353-ozqfsuh8	25	18	available	available	JJ
cord-311353-ozqfsuh8	25	19	,	,	,
cord-311353-ozqfsuh8	25	20	other	other	JJ
cord-311353-ozqfsuh8	25	21	than	than	IN
cord-311353-ozqfsuh8	25	22	supportive	supportive	JJ
cord-311353-ozqfsuh8	25	23	care	care	NN
cord-311353-ozqfsuh8	25	24	.	.	.
cord-311353-ozqfsuh8	26	1	On	on	IN
cord-311353-ozqfsuh8	26	2	January	January	NNP
cord-311353-ozqfsuh8	26	3	20	20	CD
cord-311353-ozqfsuh8	26	4	,	,	,
cord-311353-ozqfsuh8	26	5	2020	2020	CD
cord-311353-ozqfsuh8	26	6	,	,	,
cord-311353-ozqfsuh8	26	7	National	National	NNP
cord-311353-ozqfsuh8	26	8	Health	Health	NNP
cord-311353-ozqfsuh8	26	9	Commission	Commission	NNP
cord-311353-ozqfsuh8	26	10	of	of	IN
cord-311353-ozqfsuh8	26	11	the	the	DT
cord-311353-ozqfsuh8	26	12	People	People	NNPS
cord-311353-ozqfsuh8	26	13	's	's	POS
cord-311353-ozqfsuh8	26	14	Republic	Republic	NNP
cord-311353-ozqfsuh8	26	15	of	of	IN
cord-311353-ozqfsuh8	26	16	China	China	NNP
cord-311353-ozqfsuh8	26	17	announced	announce	VBD
cord-311353-ozqfsuh8	26	18	that	that	IN
cord-311353-ozqfsuh8	26	19	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	26	20	would	would	MD
cord-311353-ozqfsuh8	26	21	be	be	VB
cord-311353-ozqfsuh8	26	22	classified	classify	VBN
cord-311353-ozqfsuh8	26	23	as	as	IN
cord-311353-ozqfsuh8	26	24	category	category	NN
cord-311353-ozqfsuh8	26	25	A	a	DT
cord-311353-ozqfsuh8	26	26	infectious	infectious	JJ
cord-311353-ozqfsuh8	26	27	disease	disease	NN
cord-311353-ozqfsuh8	26	28	[	[	-LRB-
cord-311353-ozqfsuh8	26	29	6	6	CD
cord-311353-ozqfsuh8	26	30	]	]	-RRB-
cord-311353-ozqfsuh8	26	31	.	.	.
cord-311353-ozqfsuh8	27	1	At	at	IN
cord-311353-ozqfsuh8	27	2	the	the	DT
cord-311353-ozqfsuh8	27	3	same	same	JJ
cord-311353-ozqfsuh8	27	4	time	time	NN
cord-311353-ozqfsuh8	27	5	,	,	,
cord-311353-ozqfsuh8	27	6	Chinese	chinese	JJ
cord-311353-ozqfsuh8	27	7	medicine	medicine	NN
cord-311353-ozqfsuh8	27	8	experts	expert	NNS
cord-311353-ozqfsuh8	27	9	quickly	quickly	RB
cord-311353-ozqfsuh8	27	10	reached	reach	VBD
cord-311353-ozqfsuh8	27	11	a	a	DT
cord-311353-ozqfsuh8	27	12	consensus	consensus	NN
cord-311353-ozqfsuh8	27	13	on	on	IN
cord-311353-ozqfsuh8	27	14	Chinese	chinese	JJ
cord-311353-ozqfsuh8	27	15	medicine	medicine	NN
cord-311353-ozqfsuh8	27	16	(	(	-LRB-
cord-311353-ozqfsuh8	27	17	CM	cm	NN
cord-311353-ozqfsuh8	27	18	)	)	-RRB-
cord-311353-ozqfsuh8	27	19	therapy	therapy	NN
cord-311353-ozqfsuh8	27	20	.	.	.
cord-311353-ozqfsuh8	28	1	As	as	IN
cord-311353-ozqfsuh8	28	2	medical	medical	JJ
cord-311353-ozqfsuh8	28	3	therapy	therapy	NN
cord-311353-ozqfsuh8	28	4	,	,	,
cord-311353-ozqfsuh8	28	5	CM	CM	NNP
cord-311353-ozqfsuh8	28	6	treatment	treatment	NN
cord-311353-ozqfsuh8	28	7	was	be	VBD
cord-311353-ozqfsuh8	28	8	written	write	VBN
cord-311353-ozqfsuh8	28	9	in	in	IN
cord-311353-ozqfsuh8	28	10	"	"	``
cord-311353-ozqfsuh8	28	11	Diagnosis	Diagnosis	NNP
cord-311353-ozqfsuh8	28	12	and	and	CC
cord-311353-ozqfsuh8	28	13	Treatment	Treatment	NNP
cord-311353-ozqfsuh8	28	14	of	of	IN
cord-311353-ozqfsuh8	28	15	Pneumonia	Pneumonia	NNP
cord-311353-ozqfsuh8	28	16	Infected	infect	VBN
cord-311353-ozqfsuh8	28	17	by	by	IN
cord-311353-ozqfsuh8	28	18	2019-nCoV	2019-ncov	CD
cord-311353-ozqfsuh8	29	1	(	(	-LRB-
cord-311353-ozqfsuh8	29	2	trial	trial	NN
cord-311353-ozqfsuh8	29	3	implementation	implementation	NN
cord-311353-ozqfsuh8	29	4	7th	7th	NNP
cord-311353-ozqfsuh8	29	5	Edition	Edition	NNP
cord-311353-ozqfsuh8	29	6	)	)	-RRB-
cord-311353-ozqfsuh8	29	7	"	"	''
cord-311353-ozqfsuh8	29	8	published	publish	VBN
cord-311353-ozqfsuh8	29	9	by	by	IN
cord-311353-ozqfsuh8	29	10	National	National	NNP
cord-311353-ozqfsuh8	29	11	Health	Health	NNP
cord-311353-ozqfsuh8	29	12	Commission	Commission	NNP
cord-311353-ozqfsuh8	29	13	of	of	IN
cord-311353-ozqfsuh8	29	14	the	the	DT
cord-311353-ozqfsuh8	29	15	People	People	NNPS
cord-311353-ozqfsuh8	29	16	's	's	POS
cord-311353-ozqfsuh8	29	17	Republic	Republic	NNP
cord-311353-ozqfsuh8	29	18	of	of	IN
cord-311353-ozqfsuh8	29	19	China	China	NNP
cord-311353-ozqfsuh8	29	20	[	[	-LRB-
cord-311353-ozqfsuh8	29	21	7	7	CD
cord-311353-ozqfsuh8	29	22	]	]	-RRB-
cord-311353-ozqfsuh8	29	23	.	.	.
cord-311353-ozqfsuh8	30	1	However	however	RB
cord-311353-ozqfsuh8	30	2	,	,	,
cord-311353-ozqfsuh8	30	3	compared	compare	VBN
cord-311353-ozqfsuh8	30	4	with	with	IN
cord-311353-ozqfsuh8	30	5	conventional	conventional	JJ
cord-311353-ozqfsuh8	30	6	treatment	treatment	NN
cord-311353-ozqfsuh8	30	7	,	,	,
cord-311353-ozqfsuh8	30	8	there	there	EX
cord-311353-ozqfsuh8	30	9	is	be	VBZ
cord-311353-ozqfsuh8	30	10	no	no	DT
cord-311353-ozqfsuh8	30	11	high	high	JJ
cord-311353-ozqfsuh8	30	12	-	-	HYPH
cord-311353-ozqfsuh8	30	13	level	level	NN
cord-311353-ozqfsuh8	30	14	evidence	evidence	NN
cord-311353-ozqfsuh8	30	15	to	to	TO
cord-311353-ozqfsuh8	30	16	support	support	VB
cord-311353-ozqfsuh8	30	17	the	the	DT
cord-311353-ozqfsuh8	30	18	effectiveness	effectiveness	NN
cord-311353-ozqfsuh8	30	19	of	of	IN
cord-311353-ozqfsuh8	30	20	CM	cm	NN
cord-311353-ozqfsuh8	30	21	treatment	treatment	NN
cord-311353-ozqfsuh8	30	22	.	.	.
cord-311353-ozqfsuh8	31	1	Therefore	therefore	RB
cord-311353-ozqfsuh8	31	2	,	,	,
cord-311353-ozqfsuh8	31	3	the	the	DT
cord-311353-ozqfsuh8	31	4	meta	meta	JJ
cord-311353-ozqfsuh8	31	5	-	-	HYPH
cord-311353-ozqfsuh8	31	6	analysis	analysis	NN
cord-311353-ozqfsuh8	31	7	method	method	NN
cord-311353-ozqfsuh8	31	8	will	will	MD
cord-311353-ozqfsuh8	31	9	be	be	VB
cord-311353-ozqfsuh8	31	10	used	use	VBN
cord-311353-ozqfsuh8	31	11	to	to	TO
cord-311353-ozqfsuh8	31	12	systematically	systematically	RB
cord-311353-ozqfsuh8	31	13	review	review	VB
cord-311353-ozqfsuh8	31	14	the	the	DT
cord-311353-ozqfsuh8	31	15	clinical	clinical	JJ
cord-311353-ozqfsuh8	31	16	efficacy	efficacy	NN
cord-311353-ozqfsuh8	31	17	and	and	CC
cord-311353-ozqfsuh8	31	18	safety	safety	NN
cord-311353-ozqfsuh8	31	19	of	of	IN
cord-311353-ozqfsuh8	31	20	CM	CM	NNP
cord-311353-ozqfsuh8	31	21	for	for	IN
cord-311353-ozqfsuh8	31	22	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	31	23	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	31	24	.	.	.
cord-311353-ozqfsuh8	32	1	This	this	DT
cord-311353-ozqfsuh8	32	2	analysis	analysis	NN
cord-311353-ozqfsuh8	32	3	is	be	VBZ
cord-311353-ozqfsuh8	32	4	expected	expect	VBN
cord-311353-ozqfsuh8	32	5	to	to	TO
cord-311353-ozqfsuh8	32	6	obtain	obtain	VB
cord-311353-ozqfsuh8	32	7	meaningful	meaningful	JJ
cord-311353-ozqfsuh8	32	8	conclusions	conclusion	NNS
cord-311353-ozqfsuh8	32	9	and	and	CC
cord-311353-ozqfsuh8	32	10	provide	provide	VB
cord-311353-ozqfsuh8	32	11	a	a	DT
cord-311353-ozqfsuh8	32	12	high	high	JJ
cord-311353-ozqfsuh8	32	13	level	level	NN
cord-311353-ozqfsuh8	32	14	of	of	IN
cord-311353-ozqfsuh8	32	15	evidence	evidence	NN
cord-311353-ozqfsuh8	32	16	-	-	HYPH
cord-311353-ozqfsuh8	32	17	based	base	VBN
cord-311353-ozqfsuh8	32	18	medicine	medicine	NN
cord-311353-ozqfsuh8	32	19	evidence	evidence	NN
cord-311353-ozqfsuh8	32	20	.	.	.
cord-311353-ozqfsuh8	33	1	Studies	study	NNS
cord-311353-ozqfsuh8	33	2	meeting	meet	VBG
cord-311353-ozqfsuh8	33	3	the	the	DT
cord-311353-ozqfsuh8	33	4	following	follow	VBG
cord-311353-ozqfsuh8	33	5	criteria	criterion	NNS
cord-311353-ozqfsuh8	33	6	were	be	VBD
cord-311353-ozqfsuh8	33	7	included	include	VBN
cord-311353-ozqfsuh8	33	8	:	:	:
cord-311353-ozqfsuh8	33	9	(	(	-LRB-
cord-311353-ozqfsuh8	33	10	1	1	LS
cord-311353-ozqfsuh8	33	11	)	)	-RRB-
cord-311353-ozqfsuh8	33	12	randomized	randomize	VBN
cord-311353-ozqfsuh8	33	13	controlled	control	VBN
cord-311353-ozqfsuh8	33	14	trials	trial	NNS
cord-311353-ozqfsuh8	33	15	(	(	-LRB-
cord-311353-ozqfsuh8	33	16	RCTs	RCTs	NNP
cord-311353-ozqfsuh8	33	17	)	)	-RRB-
cord-311353-ozqfsuh8	33	18	using	use	VBG
cord-311353-ozqfsuh8	33	19	CM	cm	NN
cord-311353-ozqfsuh8	33	20	(	(	-LRB-
cord-311353-ozqfsuh8	33	21	including	include	VBG
cord-311353-ozqfsuh8	33	22	Chinese	chinese	JJ
cord-311353-ozqfsuh8	33	23	herbal	herbal	JJ
cord-311353-ozqfsuh8	33	24	medicine	medicine	NN
cord-311353-ozqfsuh8	33	25	,	,	,
cord-311353-ozqfsuh8	33	26	Chinese	chinese	JJ
cord-311353-ozqfsuh8	33	27	patent	patent	NN
cord-311353-ozqfsuh8	33	28	medicine	medicine	NN
cord-311353-ozqfsuh8	33	29	and	and	CC
cord-311353-ozqfsuh8	33	30	Chinese	chinese	JJ
cord-311353-ozqfsuh8	33	31	medicine	medicine	NN
cord-311353-ozqfsuh8	33	32	injections	injection	NNS
cord-311353-ozqfsuh8	33	33	)	)	-RRB-
cord-311353-ozqfsuh8	33	34	to	to	TO
cord-311353-ozqfsuh8	33	35	treat	treat	VB
cord-311353-ozqfsuh8	33	36	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	33	37	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	33	38	regardless	regardless	RB
cord-311353-ozqfsuh8	33	39	of	of	IN
cord-311353-ozqfsuh8	33	40	J	J	NNP
cord-311353-ozqfsuh8	33	41	o	o	NNP
cord-311353-ozqfsuh8	33	42	u	u	NN
cord-311353-ozqfsuh8	33	43	r	r	NNP
cord-311353-ozqfsuh8	33	44	n	n	NN
cord-311353-ozqfsuh8	33	45	a	a	DT
cord-311353-ozqfsuh8	33	46	l	l	NN
cord-311353-ozqfsuh8	33	47	P	p	NN
cord-311353-ozqfsuh8	33	48	r	r	NN
cord-311353-ozqfsuh8	33	49	e	e	NN
cord-311353-ozqfsuh8	34	1	-p	-p	NNP
cord-311353-ozqfsuh8	34	2	r	r	NN
cord-311353-ozqfsuh8	34	3	o	o	NN
cord-311353-ozqfsuh8	34	4	o	o	NN
cord-311353-ozqfsuh8	34	5	f	f	NN
cord-311353-ozqfsuh8	34	6	meta	meta	NNP
cord-311353-ozqfsuh8	34	7	-	-	HYPH
cord-311353-ozqfsuh8	34	8	analysis	analysis	NN
cord-311353-ozqfsuh8	34	9	.	.	.
cord-311353-ozqfsuh8	35	1	If	if	IN
cord-311353-ozqfsuh8	35	2	two	two	CD
cord-311353-ozqfsuh8	35	3	or	or	CC
cord-311353-ozqfsuh8	35	4	more	more	RBR
cord-311353-ozqfsuh8	35	5	homogeneous	homogeneous	JJ
cord-311353-ozqfsuh8	35	6	studies	study	NNS
cord-311353-ozqfsuh8	35	7	are	be	VBP
cord-311353-ozqfsuh8	35	8	available	available	JJ
cord-311353-ozqfsuh8	35	9	,	,	,
cord-311353-ozqfsuh8	35	10	we	-PRON-	PRP
cord-311353-ozqfsuh8	35	11	will	will	MD
cord-311353-ozqfsuh8	35	12	use	use	VB
cord-311353-ozqfsuh8	35	13	aggregated	aggregated	JJ
cord-311353-ozqfsuh8	35	14	data	datum	NNS
cord-311353-ozqfsuh8	35	15	for	for	IN
cord-311353-ozqfsuh8	35	16	meta	meta	NNP
cord-311353-ozqfsuh8	35	17	-	-	HYPH
cord-311353-ozqfsuh8	35	18	analysis	analysis	NN
cord-311353-ozqfsuh8	35	19	.	.	.
cord-311353-ozqfsuh8	36	1	If	if	IN
cord-311353-ozqfsuh8	36	2	the	the	DT
cord-311353-ozqfsuh8	36	3	data	datum	NNS
cord-311353-ozqfsuh8	36	4	are	be	VBP
cord-311353-ozqfsuh8	36	5	not	not	RB
cord-311353-ozqfsuh8	36	6	available	available	JJ
cord-311353-ozqfsuh8	36	7	for	for	IN
cord-311353-ozqfsuh8	36	8	quantitative	quantitative	JJ
cord-311353-ozqfsuh8	36	9	analysis	analysis	NN
cord-311353-ozqfsuh8	36	10	,	,	,
cord-311353-ozqfsuh8	36	11	we	-PRON-	PRP
cord-311353-ozqfsuh8	36	12	will	will	MD
cord-311353-ozqfsuh8	36	13	report	report	VB
cord-311353-ozqfsuh8	36	14	result	result	VB
cord-311353-ozqfsuh8	36	15	by	by	IN
cord-311353-ozqfsuh8	36	16	qualitative	qualitative	JJ
cord-311353-ozqfsuh8	36	17	description	description	NN
cord-311353-ozqfsuh8	36	18	.	.	.
cord-311353-ozqfsuh8	37	1	For	for	IN
cord-311353-ozqfsuh8	37	2	dichotomous	dichotomous	JJ
cord-311353-ozqfsuh8	37	3	outcomes	outcome	NNS
cord-311353-ozqfsuh8	37	4	,	,	,
cord-311353-ozqfsuh8	37	5	we	-PRON-	PRP
cord-311353-ozqfsuh8	37	6	calculated	calculate	VBD
cord-311353-ozqfsuh8	37	7	the	the	DT
cord-311353-ozqfsuh8	37	8	risk	risk	NN
cord-311353-ozqfsuh8	37	9	ratio	ratio	NN
cord-311353-ozqfsuh8	37	10	(	(	-LRB-
cord-311353-ozqfsuh8	37	11	RR	RR	NNP
cord-311353-ozqfsuh8	37	12	)	)	-RRB-
cord-311353-ozqfsuh8	37	13	,	,	,
cord-311353-ozqfsuh8	37	14	95	95	CD
cord-311353-ozqfsuh8	37	15	%	%	NN
cord-311353-ozqfsuh8	37	16	confidence	confidence	NN
cord-311353-ozqfsuh8	37	17	intervals	interval	NNS
cord-311353-ozqfsuh8	37	18	(	(	-LRB-
cord-311353-ozqfsuh8	37	19	CI	CI	NNP
cord-311353-ozqfsuh8	37	20	)	)	-RRB-
cord-311353-ozqfsuh8	37	21	and	and	CC
cord-311353-ozqfsuh8	37	22	P	p	NN
cord-311353-ozqfsuh8	37	23	values	value	NNS
cord-311353-ozqfsuh8	37	24	.	.	.
cord-311353-ozqfsuh8	38	1	For	for	IN
cord-311353-ozqfsuh8	38	2	continuous	continuous	JJ
cord-311353-ozqfsuh8	38	3	variable	variable	NN
cord-311353-ozqfsuh8	38	4	,	,	,
cord-311353-ozqfsuh8	38	5	we	-PRON-	PRP
cord-311353-ozqfsuh8	38	6	calculated	calculate	VBD
cord-311353-ozqfsuh8	38	7	the	the	DT
cord-311353-ozqfsuh8	38	8	mean	mean	JJ
cord-311353-ozqfsuh8	38	9	difference	difference	NN
cord-311353-ozqfsuh8	38	10	(	(	-LRB-
cord-311353-ozqfsuh8	38	11	MD	MD	NNP
cord-311353-ozqfsuh8	38	12	)	)	-RRB-
cord-311353-ozqfsuh8	38	13	,	,	,
cord-311353-ozqfsuh8	38	14	95	95	CD
cord-311353-ozqfsuh8	38	15	%	%	NN
cord-311353-ozqfsuh8	38	16	CI	ci	NN
cord-311353-ozqfsuh8	38	17	and	and	CC
cord-311353-ozqfsuh8	38	18	P	p	NN
cord-311353-ozqfsuh8	38	19	values	value	NNS
cord-311353-ozqfsuh8	38	20	.	.	.
cord-311353-ozqfsuh8	39	1	We	-PRON-	PRP
cord-311353-ozqfsuh8	39	2	used	use	VBD
cord-311353-ozqfsuh8	39	3	the	the	DT
cord-311353-ozqfsuh8	39	4	inverse	inverse	JJ
cord-311353-ozqfsuh8	39	5	variance	variance	NN
cord-311353-ozqfsuh8	39	6	method	method	NN
cord-311353-ozqfsuh8	39	7	to	to	TO
cord-311353-ozqfsuh8	39	8	calculate	calculate	VB
cord-311353-ozqfsuh8	39	9	pooled	pool	VBN
cord-311353-ozqfsuh8	39	10	MD	MD	NNP
cord-311353-ozqfsuh8	39	11	values	value	NNS
cord-311353-ozqfsuh8	39	12	and	and	CC
cord-311353-ozqfsuh8	39	13	the	the	DT
cord-311353-ozqfsuh8	39	14	Mantel	Mantel	NNP
cord-311353-ozqfsuh8	39	15	-	-	HYPH
cord-311353-ozqfsuh8	39	16	Haenszel	Haenszel	NNP
cord-311353-ozqfsuh8	39	17	estimator	estimator	NN
cord-311353-ozqfsuh8	39	18	to	to	TO
cord-311353-ozqfsuh8	39	19	calculate	calculate	VB
cord-311353-ozqfsuh8	39	20	RR	RR	NNP
cord-311353-ozqfsuh8	39	21	.	.	.
cord-311353-ozqfsuh8	40	1	Studies	study	NNS
cord-311353-ozqfsuh8	40	2	will	will	MD
cord-311353-ozqfsuh8	40	3	be	be	VB
cord-311353-ozqfsuh8	40	4	evaluated	evaluate	VBN
cord-311353-ozqfsuh8	40	5	for	for	IN
cord-311353-ozqfsuh8	40	6	heterogeneity	heterogeneity	NN
cord-311353-ozqfsuh8	40	7	using	use	VBG
cord-311353-ozqfsuh8	40	8	I	-PRON-	PRP
cord-311353-ozqfsuh8	40	9	squared	square	VBD
cord-311353-ozqfsuh8	40	10	and	and	CC
cord-311353-ozqfsuh8	40	11	chi	chi	JJ
cord-311353-ozqfsuh8	40	12	-	-	HYPH
cord-311353-ozqfsuh8	40	13	squared	squared	JJ
cord-311353-ozqfsuh8	40	14	test	test	NN
cord-311353-ozqfsuh8	40	15	.	.	.
cord-311353-ozqfsuh8	41	1	If	if	IN
cord-311353-ozqfsuh8	41	2	I	-PRON-	PRP
cord-311353-ozqfsuh8	41	3	2	2	CD
cord-311353-ozqfsuh8	41	4	>	>	SYM
cord-311353-ozqfsuh8	41	5	50	50	CD
cord-311353-ozqfsuh8	41	6	%	%	NN
cord-311353-ozqfsuh8	41	7	,	,	,
cord-311353-ozqfsuh8	41	8	or	or	CC
cord-311353-ozqfsuh8	41	9	P0.05	P0.05	NNP
cord-311353-ozqfsuh8	41	10	,	,	,
cord-311353-ozqfsuh8	41	11	the	the	DT
cord-311353-ozqfsuh8	41	12	studies	study	NNS
cord-311353-ozqfsuh8	41	13	will	will	MD
cord-311353-ozqfsuh8	41	14	be	be	VB
cord-311353-ozqfsuh8	41	15	considered	consider	VBN
cord-311353-ozqfsuh8	41	16	heterogeneous	heterogeneous	JJ
cord-311353-ozqfsuh8	41	17	,	,	,
cord-311353-ozqfsuh8	41	18	and	and	CC
cord-311353-ozqfsuh8	41	19	the	the	DT
cord-311353-ozqfsuh8	41	20	pooling	pooling	NN
cord-311353-ozqfsuh8	41	21	model	model	NN
cord-311353-ozqfsuh8	41	22	will	will	MD
cord-311353-ozqfsuh8	41	23	choose	choose	VB
cord-311353-ozqfsuh8	41	24	a	a	DT
cord-311353-ozqfsuh8	41	25	random	random	JJ
cord-311353-ozqfsuh8	41	26	effects	effect	NNS
cord-311353-ozqfsuh8	41	27	model	model	NN
cord-311353-ozqfsuh8	41	28	,	,	,
cord-311353-ozqfsuh8	41	29	otherwise	otherwise	RB
cord-311353-ozqfsuh8	41	30	fixed	fix	VBN
cord-311353-ozqfsuh8	41	31	effects	effect	NNS
cord-311353-ozqfsuh8	41	32	model	model	NN
cord-311353-ozqfsuh8	41	33	will	will	MD
cord-311353-ozqfsuh8	41	34	be	be	VB
cord-311353-ozqfsuh8	41	35	used	use	VBN
cord-311353-ozqfsuh8	41	36	.	.	.
cord-311353-ozqfsuh8	42	1	The	the	DT
cord-311353-ozqfsuh8	42	2	funnel	funnel	NN
cord-311353-ozqfsuh8	42	3	plot	plot	NN
cord-311353-ozqfsuh8	42	4	will	will	MD
cord-311353-ozqfsuh8	42	5	be	be	VB
cord-311353-ozqfsuh8	42	6	used	use	VBN
cord-311353-ozqfsuh8	42	7	to	to	TO
cord-311353-ozqfsuh8	42	8	evaluate	evaluate	VB
cord-311353-ozqfsuh8	42	9	publication	publication	NN
cord-311353-ozqfsuh8	42	10	bias	bias	NN
cord-311353-ozqfsuh8	42	11	.	.	.
cord-311353-ozqfsuh8	43	1	716	716	CD
cord-311353-ozqfsuh8	43	2	unique	unique	JJ
cord-311353-ozqfsuh8	43	3	citations	citation	NNS
cord-311353-ozqfsuh8	43	4	were	be	VBD
cord-311353-ozqfsuh8	43	5	identified	identify	VBN
cord-311353-ozqfsuh8	43	6	from	from	IN
cord-311353-ozqfsuh8	43	7	electronic	electronic	JJ
cord-311353-ozqfsuh8	43	8	database	database	NN
cord-311353-ozqfsuh8	43	9	.	.	.
cord-311353-ozqfsuh8	44	1	After	after	IN
cord-311353-ozqfsuh8	44	2	duplicates	duplicate	NNS
cord-311353-ozqfsuh8	44	3	removed	remove	VBN
cord-311353-ozqfsuh8	44	4	,	,	,
cord-311353-ozqfsuh8	44	5	697	697	CD
cord-311353-ozqfsuh8	44	6	literature	literature	NN
cord-311353-ozqfsuh8	44	7	remained	remain	VBD
cord-311353-ozqfsuh8	44	8	.	.	.
cord-311353-ozqfsuh8	45	1	By	by	IN
cord-311353-ozqfsuh8	45	2	reading	read	VBG
cord-311353-ozqfsuh8	45	3	titles	title	NNS
cord-311353-ozqfsuh8	45	4	and	and	CC
cord-311353-ozqfsuh8	45	5	abstracts	abstract	NNS
cord-311353-ozqfsuh8	45	6	,	,	,
cord-311353-ozqfsuh8	45	7	42	42	CD
cord-311353-ozqfsuh8	45	8	articles	article	NNS
cord-311353-ozqfsuh8	45	9	were	be	VBD
cord-311353-ozqfsuh8	45	10	downloaded	download	VBN
cord-311353-ozqfsuh8	45	11	.	.	.
cord-311353-ozqfsuh8	46	1	A	a	DT
cord-311353-ozqfsuh8	46	2	total	total	NN
cord-311353-ozqfsuh8	46	3	of	of	IN
cord-311353-ozqfsuh8	46	4	42	42	CD
cord-311353-ozqfsuh8	46	5	articles	article	NNS
cord-311353-ozqfsuh8	46	6	were	be	VBD
cord-311353-ozqfsuh8	46	7	retrieved	retrieve	VBN
cord-311353-ozqfsuh8	46	8	for	for	IN
cord-311353-ozqfsuh8	46	9	further	further	JJ
cord-311353-ozqfsuh8	46	10	assessment	assessment	NN
cord-311353-ozqfsuh8	46	11	,	,	,
cord-311353-ozqfsuh8	46	12	among	among	IN
cord-311353-ozqfsuh8	46	13	which	which	WDT
cord-311353-ozqfsuh8	46	14	35	35	CD
cord-311353-ozqfsuh8	46	15	were	be	VBD
cord-311353-ozqfsuh8	46	16	further	further	RB
cord-311353-ozqfsuh8	46	17	excluded	exclude	VBN
cord-311353-ozqfsuh8	46	18	,	,	,
cord-311353-ozqfsuh8	46	19	for	for	IN
cord-311353-ozqfsuh8	46	20	the	the	DT
cord-311353-ozqfsuh8	46	21	reasons	reason	NNS
cord-311353-ozqfsuh8	46	22	:	:	:
cord-311353-ozqfsuh8	46	23	wrong	wrong	JJ
cord-311353-ozqfsuh8	46	24	patient	patient	JJ
cord-311353-ozqfsuh8	46	25	population	population	NN
cord-311353-ozqfsuh8	46	26	;	;	,
cord-311353-ozqfsuh8	46	27	self	self	NN
cord-311353-ozqfsuh8	46	28	-	-	HYPH
cord-311353-ozqfsuh8	46	29	control	control	NN
cord-311353-ozqfsuh8	46	30	;	;	:
cord-311353-ozqfsuh8	46	31	retrospective	retrospective	JJ
cord-311353-ozqfsuh8	46	32	studies	study	NNS
cord-311353-ozqfsuh8	46	33	.	.	.
cord-311353-ozqfsuh8	47	1	In	in	IN
cord-311353-ozqfsuh8	47	2	total	total	JJ
cord-311353-ozqfsuh8	47	3	,	,	,
cord-311353-ozqfsuh8	47	4	seven	seven	CD
cord-311353-ozqfsuh8	47	5	[	[	-LRB-
cord-311353-ozqfsuh8	47	6	9	9	CD
cord-311353-ozqfsuh8	47	7	]	]	-RRB-
cord-311353-ozqfsuh8	47	8	[	[	-LRB-
cord-311353-ozqfsuh8	47	9	10	10	CD
cord-311353-ozqfsuh8	47	10	]	]	-RRB-
cord-311353-ozqfsuh8	47	11	[	[	-LRB-
cord-311353-ozqfsuh8	47	12	11	11	CD
cord-311353-ozqfsuh8	47	13	]	]	-RRB-
cord-311353-ozqfsuh8	48	1	[	[	-LRB-
cord-311353-ozqfsuh8	48	2	12	12	CD
cord-311353-ozqfsuh8	48	3	]	]	-RRB-
cord-311353-ozqfsuh8	48	4	[	[	-LRB-
cord-311353-ozqfsuh8	48	5	13	13	CD
cord-311353-ozqfsuh8	48	6	]	]	-RRB-
cord-311353-ozqfsuh8	49	1	[	[	-LRB-
cord-311353-ozqfsuh8	49	2	14	14	CD
cord-311353-ozqfsuh8	49	3	]	]	-RRB-
cord-311353-ozqfsuh8	49	4	[	[	-LRB-
cord-311353-ozqfsuh8	49	5	15	15	CD
cord-311353-ozqfsuh8	49	6	]	]	-RRB-
cord-311353-ozqfsuh8	50	1	RCTs	RCTs	NNP
cord-311353-ozqfsuh8	50	2	met	meet	VBD
cord-311353-ozqfsuh8	50	3	the	the	DT
cord-311353-ozqfsuh8	50	4	inclusion	inclusion	NN
cord-311353-ozqfsuh8	50	5	criteria	criterion	NNS
cord-311353-ozqfsuh8	50	6	and	and	CC
cord-311353-ozqfsuh8	50	7	were	be	VBD
cord-311353-ozqfsuh8	50	8	subjected	subject	VBN
cord-311353-ozqfsuh8	50	9	to	to	IN
cord-311353-ozqfsuh8	50	10	data	data	NN
cord-311353-ozqfsuh8	50	11	extraction	extraction	NN
cord-311353-ozqfsuh8	50	12	(	(	-LRB-
cord-311353-ozqfsuh8	50	13	Figure	figure	NN
cord-311353-ozqfsuh8	50	14	1	1	CD
cord-311353-ozqfsuh8	50	15	)	)	-RRB-
cord-311353-ozqfsuh8	50	16	.	.	.
cord-311353-ozqfsuh8	51	1	All	all	DT
cord-311353-ozqfsuh8	51	2	studies	study	NNS
cord-311353-ozqfsuh8	51	3	included	include	VBD
cord-311353-ozqfsuh8	51	4	involved	involve	VBD
cord-311353-ozqfsuh8	51	5	seven	seven	CD
cord-311353-ozqfsuh8	51	6	RCTs	rct	NNS
cord-311353-ozqfsuh8	51	7	with	with	IN
cord-311353-ozqfsuh8	51	8	681	681	CD
cord-311353-ozqfsuh8	51	9	patients	patient	NNS
cord-311353-ozqfsuh8	51	10	.	.	.
cord-311353-ozqfsuh8	52	1	Of	of	IN
cord-311353-ozqfsuh8	52	2	the	the	DT
cord-311353-ozqfsuh8	52	3	seven	seven	CD
cord-311353-ozqfsuh8	52	4	RCTs	RCTs	NNPS
cord-311353-ozqfsuh8	52	5	,	,	,
cord-311353-ozqfsuh8	52	6	two	two	CD
cord-311353-ozqfsuh8	52	7	RCTs	rct	NNS
cord-311353-ozqfsuh8	52	8	[	[	-LRB-
cord-311353-ozqfsuh8	52	9	9	9	CD
cord-311353-ozqfsuh8	52	10	,	,	,
cord-311353-ozqfsuh8	52	11	13	13	CD
cord-311353-ozqfsuh8	52	12	]	]	-RRB-
cord-311353-ozqfsuh8	52	13	reported	report	VBN
cord-311353-ozqfsuh8	52	14	clinical	clinical	JJ
cord-311353-ozqfsuh8	52	15	effective	effective	JJ
cord-311353-ozqfsuh8	52	16	rate	rate	NN
cord-311353-ozqfsuh8	52	17	,	,	,
cord-311353-ozqfsuh8	52	18	seven	seven	CD
cord-311353-ozqfsuh8	52	19	RCTs	rct	NNS
cord-311353-ozqfsuh8	52	20	[	[	-LRB-
cord-311353-ozqfsuh8	52	21	9	9	CD
cord-311353-ozqfsuh8	52	22	]	]	-RRB-
cord-311353-ozqfsuh8	52	23	[	[	-LRB-
cord-311353-ozqfsuh8	52	24	10	10	CD
cord-311353-ozqfsuh8	52	25	]	]	-RRB-
cord-311353-ozqfsuh8	52	26	[	[	-LRB-
cord-311353-ozqfsuh8	52	27	11	11	CD
cord-311353-ozqfsuh8	52	28	]	]	-RRB-
cord-311353-ozqfsuh8	52	29	[	[	-LRB-
cord-311353-ozqfsuh8	52	30	12	12	CD
cord-311353-ozqfsuh8	52	31	]	]	-RRB-
cord-311353-ozqfsuh8	52	32	[	[	-LRB-
cord-311353-ozqfsuh8	52	33	13	13	CD
cord-311353-ozqfsuh8	52	34	]	]	-RRB-
cord-311353-ozqfsuh8	52	35	[	[	-LRB-
cord-311353-ozqfsuh8	52	36	14	14	CD
cord-311353-ozqfsuh8	52	37	]	]	-RRB-
cord-311353-ozqfsuh8	52	38	[	[	-LRB-
cord-311353-ozqfsuh8	52	39	15	15	CD
cord-311353-ozqfsuh8	52	40	]	]	-RRB-
cord-311353-ozqfsuh8	52	41	recorded	record	VBN
cord-311353-ozqfsuh8	52	42	incidence	incidence	NN
cord-311353-ozqfsuh8	52	43	of	of	IN
cord-311353-ozqfsuh8	52	44	adverse	adverse	JJ
cord-311353-ozqfsuh8	52	45	reactions	reaction	NNS
cord-311353-ozqfsuh8	52	46	,	,	,
cord-311353-ozqfsuh8	52	47	three	three	CD
cord-311353-ozqfsuh8	52	48	RCTs	RCTs	NNPS
cord-311353-ozqfsuh8	52	49	[	[	-LRB-
cord-311353-ozqfsuh8	52	50	10	10	CD
cord-311353-ozqfsuh8	52	51	,	,	,
cord-311353-ozqfsuh8	52	52	11	11	CD
cord-311353-ozqfsuh8	52	53	,	,	,
cord-311353-ozqfsuh8	52	54	14	14	CD
cord-311353-ozqfsuh8	52	55	]	]	-RRB-
cord-311353-ozqfsuh8	52	56	reported	report	VBN
cord-311353-ozqfsuh8	52	57	viral	viral	JJ
cord-311353-ozqfsuh8	52	58	nucleic	nucleic	JJ
cord-311353-ozqfsuh8	52	59	acid	acid	NN
cord-311353-ozqfsuh8	52	60	negative	negative	JJ
cord-311353-ozqfsuh8	52	61	conversion	conversion	NN
cord-311353-ozqfsuh8	52	62	rate	rate	NN
cord-311353-ozqfsuh8	52	63	,	,	,
cord-311353-ozqfsuh8	52	64	four	four	CD
cord-311353-ozqfsuh8	52	65	RCTs	RCTs	NNPS
cord-311353-ozqfsuh8	52	66	[	[	-LRB-
cord-311353-ozqfsuh8	52	67	10	10	CD
cord-311353-ozqfsuh8	52	68	,	,	,
cord-311353-ozqfsuh8	52	69	[	[	-LRB-
cord-311353-ozqfsuh8	52	70	12	12	CD
cord-311353-ozqfsuh8	52	71	]	]	-RRB-
cord-311353-ozqfsuh8	52	72	[	[	-LRB-
cord-311353-ozqfsuh8	52	73	13	13	CD
cord-311353-ozqfsuh8	52	74	]	]	-RRB-
cord-311353-ozqfsuh8	52	75	[	[	-LRB-
cord-311353-ozqfsuh8	52	76	14	14	CD
cord-311353-ozqfsuh8	52	77	]	]	-RRB-
cord-311353-ozqfsuh8	52	78	recorded	record	VBN
cord-311353-ozqfsuh8	52	79	remission	remission	NN
cord-311353-ozqfsuh8	52	80	rate	rate	NN
cord-311353-ozqfsuh8	52	81	of	of	IN
cord-311353-ozqfsuh8	52	82	pulmonary	pulmonary	JJ
cord-311353-ozqfsuh8	52	83	inflammation	inflammation	NN
cord-311353-ozqfsuh8	52	84	(	(	-LRB-
cord-311353-ozqfsuh8	52	85	chest	chest	NN
cord-311353-ozqfsuh8	52	86	CT	CT	NNP
cord-311353-ozqfsuh8	52	87	)	)	-RRB-
cord-311353-ozqfsuh8	52	88	.	.	.
cord-311353-ozqfsuh8	53	1	There	there	EX
cord-311353-ozqfsuh8	53	2	were	be	VBD
cord-311353-ozqfsuh8	53	3	three	three	CD
cord-311353-ozqfsuh8	53	4	RCTs	rct	NNS
cord-311353-ozqfsuh8	53	5	[	[	-LRB-
cord-311353-ozqfsuh8	53	6	9	9	CD
cord-311353-ozqfsuh8	53	7	,	,	,
cord-311353-ozqfsuh8	53	8	13	13	CD
cord-311353-ozqfsuh8	53	9	,	,	,
cord-311353-ozqfsuh8	53	10	14	14	CD
cord-311353-ozqfsuh8	53	11	]	]	-RRB-
cord-311353-ozqfsuh8	53	12	reported	report	VBD
cord-311353-ozqfsuh8	53	13	white	white	JJ
cord-311353-ozqfsuh8	53	14	blood	blood	NN
cord-311353-ozqfsuh8	53	15	cell	cell	NN
cord-311353-ozqfsuh8	53	16	count	count	NN
cord-311353-ozqfsuh8	53	17	(	(	-LRB-
cord-311353-ozqfsuh8	53	18	WBC	WBC	NNP
cord-311353-ozqfsuh8	53	19	)	)	-RRB-
cord-311353-ozqfsuh8	53	20	,	,	,
cord-311353-ozqfsuh8	53	21	three	three	CD
cord-311353-ozqfsuh8	53	22	RCTs	RCTs	NNPS
cord-311353-ozqfsuh8	53	23	[	[	-LRB-
cord-311353-ozqfsuh8	53	24	9	9	CD
cord-311353-ozqfsuh8	53	25	,	,	,
cord-311353-ozqfsuh8	53	26	10	10	CD
cord-311353-ozqfsuh8	53	27	,	,	,
cord-311353-ozqfsuh8	53	28	14	14	CD
cord-311353-ozqfsuh8	53	29	]	]	-RRB-
cord-311353-ozqfsuh8	53	30	reported	report	VBN
cord-311353-ozqfsuh8	53	31	lymphocyte	lymphocyte	NN
cord-311353-ozqfsuh8	53	32	count	count	NN
cord-311353-ozqfsuh8	53	33	(	(	-LRB-
cord-311353-ozqfsuh8	53	34	LYM	LYM	NNP
cord-311353-ozqfsuh8	53	35	)	)	-RRB-
cord-311353-ozqfsuh8	53	36	,	,	.
cord-311353-ozqfsuh8	54	1	two	two	CD
cord-311353-ozqfsuh8	54	2	RCTs	RCTs	NNPS
cord-311353-ozqfsuh8	54	3	[	[	-LRB-
cord-311353-ozqfsuh8	54	4	9	9	CD
cord-311353-ozqfsuh8	54	5	,	,	,
cord-311353-ozqfsuh8	54	6	13	13	CD
cord-311353-ozqfsuh8	54	7	]	]	-RRB-
cord-311353-ozqfsuh8	54	8	reported	report	VBN
cord-311353-ozqfsuh8	54	9	lymphocyte	lymphocyte	NN
cord-311353-ozqfsuh8	54	10	ratio	ratio	NN
cord-311353-ozqfsuh8	54	11	(	(	-LRB-
cord-311353-ozqfsuh8	54	12	LYM%	LYM%	NNP
cord-311353-ozqfsuh8	54	13	)	)	-RRB-
cord-311353-ozqfsuh8	54	14	,	,	,
cord-311353-ozqfsuh8	54	15	four	four	CD
cord-311353-ozqfsuh8	54	16	RCTs	rct	NNS
cord-311353-ozqfsuh8	54	17	[	[	-LRB-
cord-311353-ozqfsuh8	54	18	9	9	CD
cord-311353-ozqfsuh8	54	19	,	,	,
cord-311353-ozqfsuh8	54	20	10	10	CD
cord-311353-ozqfsuh8	54	21	,	,	,
cord-311353-ozqfsuh8	54	22	12	12	CD
cord-311353-ozqfsuh8	54	23	,	,	,
cord-311353-ozqfsuh8	54	24	14	14	CD
cord-311353-ozqfsuh8	54	25	]	]	-RRB-
cord-311353-ozqfsuh8	54	26	reported	report	VBN
cord-311353-ozqfsuh8	54	27	C	c	NN
cord-311353-ozqfsuh8	54	28	-	-	HYPH
cord-311353-ozqfsuh8	54	29	reactive	reactive	JJ
cord-311353-ozqfsuh8	54	30	proteins	protein	NNS
cord-311353-ozqfsuh8	54	31	,	,	,
cord-311353-ozqfsuh8	54	32	and	and	CC
cord-311353-ozqfsuh8	54	33	two	two	CD
cord-311353-ozqfsuh8	54	34	RCTs	rct	NNS
cord-311353-ozqfsuh8	54	35	[	[	-LRB-
cord-311353-ozqfsuh8	54	36	12	12	CD
cord-311353-ozqfsuh8	54	37	,	,	,
cord-311353-ozqfsuh8	54	38	14	14	CD
cord-311353-ozqfsuh8	54	39	]	]	-RRB-
cord-311353-ozqfsuh8	54	40	reported	report	VBN
cord-311353-ozqfsuh8	54	41	interleukin-6	interleukin-6	NNP
cord-311353-ozqfsuh8	54	42	.	.	.
cord-311353-ozqfsuh8	55	1	The	the	DT
cord-311353-ozqfsuh8	55	2	comparison	comparison	NN
cord-311353-ozqfsuh8	55	3	of	of	IN
cord-311353-ozqfsuh8	55	4	baseline	baseline	JJ
cord-311353-ozqfsuh8	55	5	characteristics	characteristic	NNS
cord-311353-ozqfsuh8	55	6	showed	show	VBD
cord-311353-ozqfsuh8	55	7	there	there	EX
cord-311353-ozqfsuh8	55	8	were	be	VBD
cord-311353-ozqfsuh8	55	9	no	no	DT
cord-311353-ozqfsuh8	55	10	significant	significant	JJ
cord-311353-ozqfsuh8	55	11	differences	difference	NNS
cord-311353-ozqfsuh8	55	12	in	in	IN
cord-311353-ozqfsuh8	55	13	gender	gender	NN
cord-311353-ozqfsuh8	55	14	,	,	,
cord-311353-ozqfsuh8	55	15	age	age	NN
cord-311353-ozqfsuh8	55	16	,	,	,
cord-311353-ozqfsuh8	55	17	or	or	CC
cord-311353-ozqfsuh8	55	18	disease	disease	NN
cord-311353-ozqfsuh8	55	19	duration	duration	NN
cord-311353-ozqfsuh8	55	20	between	between	IN
cord-311353-ozqfsuh8	55	21	the	the	DT
cord-311353-ozqfsuh8	55	22	treatment	treatment	NN
cord-311353-ozqfsuh8	55	23	and	and	CC
cord-311353-ozqfsuh8	55	24	control	control	NN
cord-311353-ozqfsuh8	55	25	groups	group	NNS
cord-311353-ozqfsuh8	55	26	(	(	-LRB-
cord-311353-ozqfsuh8	55	27	P>0.05	P>0.05	NNP
cord-311353-ozqfsuh8	55	28	)	)	-RRB-
cord-311353-ozqfsuh8	55	29	.	.	.
cord-311353-ozqfsuh8	56	1	The	the	DT
cord-311353-ozqfsuh8	56	2	characteristics	characteristic	NNS
cord-311353-ozqfsuh8	56	3	of	of	IN
cord-311353-ozqfsuh8	56	4	the	the	DT
cord-311353-ozqfsuh8	56	5	studies	study	NNS
cord-311353-ozqfsuh8	56	6	are	be	VBP
cord-311353-ozqfsuh8	56	7	illustrated	illustrate	VBN
cord-311353-ozqfsuh8	56	8	in	in	IN
cord-311353-ozqfsuh8	56	9	Table	Table	NNP
cord-311353-ozqfsuh8	56	10	1	1	CD
cord-311353-ozqfsuh8	56	11	J	J	NNP
cord-311353-ozqfsuh8	56	12	o	o	NN
cord-311353-ozqfsuh8	56	13	u	u	NN
cord-311353-ozqfsuh8	56	14	r	r	NN
cord-311353-ozqfsuh8	56	15	n	n	NN
cord-311353-ozqfsuh8	56	16	a	a	DT
cord-311353-ozqfsuh8	56	17	l	l	NN
cord-311353-ozqfsuh8	56	18	P	p	NN
cord-311353-ozqfsuh8	56	19	r	r	NN
cord-311353-ozqfsuh8	56	20	e	e	NN
cord-311353-ozqfsuh8	56	21	-p	-p	NN
cord-311353-ozqfsuh8	57	1	r	r	NN
cord-311353-ozqfsuh8	57	2	o	o	NN
cord-311353-ozqfsuh8	57	3	o	o	NN
cord-311353-ozqfsuh8	57	4	f	f	NN
cord-311353-ozqfsuh8	58	1	For	for	IN
cord-311353-ozqfsuh8	58	2	the	the	DT
cord-311353-ozqfsuh8	58	3	eligible	eligible	JJ
cord-311353-ozqfsuh8	58	4	studies	study	NNS
cord-311353-ozqfsuh8	58	5	,	,	,
cord-311353-ozqfsuh8	58	6	three	three	CD
cord-311353-ozqfsuh8	58	7	studies	study	NNS
cord-311353-ozqfsuh8	58	8	[	[	-LRB-
cord-311353-ozqfsuh8	58	9	9	9	CD
cord-311353-ozqfsuh8	58	10	,	,	,
cord-311353-ozqfsuh8	58	11	12	12	CD
cord-311353-ozqfsuh8	58	12	,	,	,
cord-311353-ozqfsuh8	58	13	15	15	CD
cord-311353-ozqfsuh8	58	14	]	]	-RRB-
cord-311353-ozqfsuh8	58	15	 	 	_SP
cord-311353-ozqfsuh8	58	16	The	the	DT
cord-311353-ozqfsuh8	58	17	clinical	clinical	JJ
cord-311353-ozqfsuh8	58	18	effective	effective	JJ
cord-311353-ozqfsuh8	58	19	rate	rate	NN
cord-311353-ozqfsuh8	58	20	was	be	VBD
cord-311353-ozqfsuh8	58	21	tested	test	VBN
cord-311353-ozqfsuh8	58	22	in	in	IN
cord-311353-ozqfsuh8	58	23	two	two	CD
cord-311353-ozqfsuh8	58	24	RCTs	rct	NNS
cord-311353-ozqfsuh8	58	25	involved	involve	VBN
cord-311353-ozqfsuh8	58	26	273	273	CD
cord-311353-ozqfsuh8	58	27	patients	patient	NNS
cord-311353-ozqfsuh8	58	28	.	.	.
cord-311353-ozqfsuh8	59	1	The	the	DT
cord-311353-ozqfsuh8	59	2	efficacy	efficacy	NN
cord-311353-ozqfsuh8	59	3	criteria	criterion	NNS
cord-311353-ozqfsuh8	59	4	were	be	VBD
cord-311353-ozqfsuh8	59	5	predominantly	predominantly	RB
cord-311353-ozqfsuh8	59	6	based	base	VBN
cord-311353-ozqfsuh8	59	7	on	on	IN
cord-311353-ozqfsuh8	59	8	reduction	reduction	NN
cord-311353-ozqfsuh8	59	9	of	of	IN
cord-311353-ozqfsuh8	59	10	clinical	clinical	JJ
cord-311353-ozqfsuh8	59	11	symptoms	symptom	NNS
cord-311353-ozqfsuh8	59	12	and	and	CC
cord-311353-ozqfsuh8	59	13	could	could	MD
cord-311353-ozqfsuh8	59	14	be	be	VB
cord-311353-ozqfsuh8	59	15	divided	divide	VBN
cord-311353-ozqfsuh8	59	16	into	into	IN
cord-311353-ozqfsuh8	59	17	three	three	CD
cord-311353-ozqfsuh8	59	18	grades	grade	NNS
cord-311353-ozqfsuh8	59	19	:	:	:
cord-311353-ozqfsuh8	59	20	cured	cure	VBN
cord-311353-ozqfsuh8	59	21	,	,	,
cord-311353-ozqfsuh8	59	22	remarkable	remarkable	JJ
cord-311353-ozqfsuh8	59	23	recovery	recovery	NN
cord-311353-ozqfsuh8	59	24	,	,	,
cord-311353-ozqfsuh8	59	25	unrecovered	unrecovered	JJ
cord-311353-ozqfsuh8	59	26	.	.	.
cord-311353-ozqfsuh8	60	1	The	the	DT
cord-311353-ozqfsuh8	60	2	rate	rate	NN
cord-311353-ozqfsuh8	60	3	calculated	calculate	VBN
cord-311353-ozqfsuh8	60	4	by	by	IN
cord-311353-ozqfsuh8	60	5	this	this	DT
cord-311353-ozqfsuh8	60	6	formula	formula	NN
cord-311353-ozqfsuh8	60	7	:	:	:
cord-311353-ozqfsuh8	60	8	(	(	-LRB-
cord-311353-ozqfsuh8	60	9	number	number	NN
cord-311353-ozqfsuh8	60	10	of	of	IN
cord-311353-ozqfsuh8	60	11	cured	cure	VBN
cord-311353-ozqfsuh8	60	12	patients+number	patients+number	NNP
cord-311353-ozqfsuh8	60	13	of	of	IN
cord-311353-ozqfsuh8	60	14	remarkable	remarkable	JJ
cord-311353-ozqfsuh8	60	15	recovery	recovery	NN
cord-311353-ozqfsuh8	60	16	patients)/total	patients)/total	JJ
cord-311353-ozqfsuh8	60	17	number×100	number×100	NNP
cord-311353-ozqfsuh8	60	18	%	%	NN
cord-311353-ozqfsuh8	60	19	[	[	-LRB-
cord-311353-ozqfsuh8	60	20	16	16	CD
cord-311353-ozqfsuh8	60	21	]	]	-RRB-
cord-311353-ozqfsuh8	60	22	.	.	.
cord-311353-ozqfsuh8	61	1	Heterogeneity	heterogeneity	NN
cord-311353-ozqfsuh8	61	2	test	test	NN
cord-311353-ozqfsuh8	61	3	results(P=0.39	results(P=0.39	NNP
cord-311353-ozqfsuh8	61	4	,	,	,
cord-311353-ozqfsuh8	61	5	I	i	NN
cord-311353-ozqfsuh8	61	6	2	2	CD
cord-311353-ozqfsuh8	61	7	=	=	SYM
cord-311353-ozqfsuh8	61	8	0	0	CD
cord-311353-ozqfsuh8	61	9	%	%	NN
cord-311353-ozqfsuh8	61	10	)	)	-RRB-
cord-311353-ozqfsuh8	61	11	indicated	indicate	VBD
cord-311353-ozqfsuh8	61	12	that	that	IN
cord-311353-ozqfsuh8	61	13	there	there	EX
cord-311353-ozqfsuh8	61	14	were	be	VBD
cord-311353-ozqfsuh8	61	15	no	no	DT
cord-311353-ozqfsuh8	61	16	statistical	statistical	JJ
cord-311353-ozqfsuh8	61	17	significant	significant	JJ
cord-311353-ozqfsuh8	61	18	difference	difference	NN
cord-311353-ozqfsuh8	61	19	between	between	IN
cord-311353-ozqfsuh8	61	20	the	the	DT
cord-311353-ozqfsuh8	61	21	studies	study	NNS
cord-311353-ozqfsuh8	61	22	,	,	,
cord-311353-ozqfsuh8	61	23	and	and	CC
cord-311353-ozqfsuh8	61	24	the	the	DT
cord-311353-ozqfsuh8	61	25	fixed	fix	VBN
cord-311353-ozqfsuh8	61	26	effect	effect	NN
cord-311353-ozqfsuh8	61	27	model	model	NN
cord-311353-ozqfsuh8	61	28	was	be	VBD
cord-311353-ozqfsuh8	61	29	selected	select	VBN
cord-311353-ozqfsuh8	61	30	for	for	IN
cord-311353-ozqfsuh8	61	31	meta	meta	NNP
cord-311353-ozqfsuh8	61	32	-	-	HYPH
cord-311353-ozqfsuh8	61	33	analysis	analysis	NN
cord-311353-ozqfsuh8	61	34	.	.	.
cord-311353-ozqfsuh8	62	1	As	as	IN
cord-311353-ozqfsuh8	62	2	can	can	MD
cord-311353-ozqfsuh8	62	3	be	be	VB
cord-311353-ozqfsuh8	62	4	observes	observe	NNS
cord-311353-ozqfsuh8	62	5	in	in	IN
cord-311353-ozqfsuh8	62	6	Figure	Figure	NNP
cord-311353-ozqfsuh8	62	7	 	 	_SP
cord-311353-ozqfsuh8	63	1	Taking	take	VBG
cord-311353-ozqfsuh8	63	2	incidence	incidence	NN
cord-311353-ozqfsuh8	63	3	of	of	IN
cord-311353-ozqfsuh8	63	4	adverse	adverse	JJ
cord-311353-ozqfsuh8	63	5	reactions	reaction	NNS
cord-311353-ozqfsuh8	63	6	into	into	IN
cord-311353-ozqfsuh8	63	7	consideration	consideration	NN
cord-311353-ozqfsuh8	63	8	(	(	-LRB-
cord-311353-ozqfsuh8	63	9	including	include	VBG
cord-311353-ozqfsuh8	63	10	seven	seven	CD
cord-311353-ozqfsuh8	63	11	RCTs	RCTs	NNPS
cord-311353-ozqfsuh8	63	12	,	,	,
cord-311353-ozqfsuh8	63	13	681patients	681patients	NNP
cord-311353-ozqfsuh8	63	14	)	)	-RRB-
cord-311353-ozqfsuh8	63	15	,	,	,
cord-311353-ozqfsuh8	63	16	we	-PRON-	PRP
cord-311353-ozqfsuh8	63	17	noted	note	VBD
cord-311353-ozqfsuh8	63	18	there	there	EX
cord-311353-ozqfsuh8	63	19	is	be	VBZ
cord-311353-ozqfsuh8	63	20	high	high	JJ
cord-311353-ozqfsuh8	63	21	heterogeneity	heterogeneity	NN
cord-311353-ozqfsuh8	63	22	between	between	IN
cord-311353-ozqfsuh8	63	23	studies(P=0.03	studies(P=0.03	NNP
cord-311353-ozqfsuh8	63	24	,	,	,
cord-311353-ozqfsuh8	63	25	I	i	NN
cord-311353-ozqfsuh8	63	26	2	2	CD
cord-311353-ozqfsuh8	63	27	=	=	SYM
cord-311353-ozqfsuh8	63	28	62	62	CD
cord-311353-ozqfsuh8	63	29	%	%	NN
cord-311353-ozqfsuh8	63	30	)	)	-RRB-
cord-311353-ozqfsuh8	63	31	.	.	.
cord-311353-ozqfsuh8	64	1	Therefore	therefore	RB
cord-311353-ozqfsuh8	64	2	,	,	,
cord-311353-ozqfsuh8	64	3	it	-PRON-	PRP
cord-311353-ozqfsuh8	64	4	was	be	VBD
cord-311353-ozqfsuh8	64	5	decided	decide	VBN
cord-311353-ozqfsuh8	64	6	to	to	TO
cord-311353-ozqfsuh8	64	7	choose	choose	VB
cord-311353-ozqfsuh8	64	8	the	the	DT
cord-311353-ozqfsuh8	64	9	random	random	JJ
cord-311353-ozqfsuh8	64	10	effect	effect	NN
cord-311353-ozqfsuh8	64	11	model	model	NN
cord-311353-ozqfsuh8	64	12	for	for	IN
cord-311353-ozqfsuh8	64	13	meta	meta	NNP
cord-311353-ozqfsuh8	64	14	-	-	HYPH
cord-311353-ozqfsuh8	64	15	analysis	analysis	NN
cord-311353-ozqfsuh8	64	16	.	.	.
cord-311353-ozqfsuh8	64	17	 	 	_SP
cord-311353-ozqfsuh8	65	1	The	the	DT
cord-311353-ozqfsuh8	65	2	chest	chest	NN
cord-311353-ozqfsuh8	65	3	CT	CT	NNP
cord-311353-ozqfsuh8	65	4	findings	finding	NNS
cord-311353-ozqfsuh8	65	5	were	be	VBD
cord-311353-ozqfsuh8	65	6	typical	typical	JJ
cord-311353-ozqfsuh8	65	7	of	of	IN
cord-311353-ozqfsuh8	65	8	findings	finding	NNS
cord-311353-ozqfsuh8	65	9	for	for	IN
cord-311353-ozqfsuh8	65	10	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	65	11	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	65	12	[	[	-LRB-
cord-311353-ozqfsuh8	65	13	17	17	CD
cord-311353-ozqfsuh8	65	14	,	,	,
cord-311353-ozqfsuh8	65	15	18	18	CD
cord-311353-ozqfsuh8	65	16	]	]	-RRB-
cord-311353-ozqfsuh8	65	17	.	.	.
cord-311353-ozqfsuh8	66	1	Figure	figure	NN
cord-311353-ozqfsuh8	66	2	6	6	CD
cord-311353-ozqfsuh8	66	3	)	)	-RRB-
cord-311353-ozqfsuh8	66	4	.	.	.
cord-311353-ozqfsuh8	67	1	The	the	DT
cord-311353-ozqfsuh8	67	2	results	result	NNS
cord-311353-ozqfsuh8	67	3	indicated	indicate	VBD
cord-311353-ozqfsuh8	67	4	that	that	IN
cord-311353-ozqfsuh8	67	5	,	,	,
cord-311353-ozqfsuh8	67	6	compared	compare	VBN
cord-311353-ozqfsuh8	67	7	with	with	IN
cord-311353-ozqfsuh8	67	8	conventional	conventional	JJ
cord-311353-ozqfsuh8	67	9	treatment	treatment	NN
cord-311353-ozqfsuh8	67	10	alone	alone	RB
cord-311353-ozqfsuh8	67	11	,	,	,
cord-311353-ozqfsuh8	67	12	combined	combine	VBN
cord-311353-ozqfsuh8	67	13	therapy	therapy	NN
cord-311353-ozqfsuh8	67	14	with	with	IN
cord-311353-ozqfsuh8	67	15	CM	CM	NNP
cord-311353-ozqfsuh8	67	16	can	can	MD
cord-311353-ozqfsuh8	67	17	significantly	significantly	RB
cord-311353-ozqfsuh8	67	18	reduce	reduce	VB
cord-311353-ozqfsuh8	67	19	pulmonary	pulmonary	JJ
cord-311353-ozqfsuh8	67	20	inflammation	inflammation	NN
cord-311353-ozqfsuh8	67	21	(	(	-LRB-
cord-311353-ozqfsuh8	67	22	chest	chest	NN
cord-311353-ozqfsuh8	67	23	CT	CT	NNP
cord-311353-ozqfsuh8	67	24	)	)	-RRB-
cord-311353-ozqfsuh8	67	25	.	.	.
cord-311353-ozqfsuh8	68	1	[	[	-LRB-
cord-311353-ozqfsuh8	68	2	27	27	CD
cord-311353-ozqfsuh8	68	3	]	]	-RRB-
cord-311353-ozqfsuh8	68	4	[	[	-LRB-
cord-311353-ozqfsuh8	68	5	28	28	CD
cord-311353-ozqfsuh8	68	6	]	]	-RRB-
cord-311353-ozqfsuh8	68	7	[	[	-LRB-
cord-311353-ozqfsuh8	68	8	29	29	CD
cord-311353-ozqfsuh8	68	9	]	]	-RRB-
cord-311353-ozqfsuh8	68	10	.	.	.
cord-311353-ozqfsuh8	69	1	These	these	DT
cord-311353-ozqfsuh8	69	2	immunological	immunological	JJ
cord-311353-ozqfsuh8	69	3	markers	marker	NNS
cord-311353-ozqfsuh8	69	4	may	may	MD
cord-311353-ozqfsuh8	69	5	be	be	VB
cord-311353-ozqfsuh8	69	6	of	of	IN
cord-311353-ozqfsuh8	69	7	importance	importance	NN
cord-311353-ozqfsuh8	69	8	due	due	IN
cord-311353-ozqfsuh8	69	9	to	to	IN
cord-311353-ozqfsuh8	69	10	their	-PRON-	PRP$
cord-311353-ozqfsuh8	69	11	correlation	correlation	NN
cord-311353-ozqfsuh8	69	12	with	with	IN
cord-311353-ozqfsuh8	69	13	disease	disease	NN
cord-311353-ozqfsuh8	69	14	severity	severity	NN
cord-311353-ozqfsuh8	69	15	in	in	IN
cord-311353-ozqfsuh8	69	16	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	69	17	.	.	.
cord-311353-ozqfsuh8	70	1	There	there	EX
cord-311353-ozqfsuh8	70	2	are	be	VBP
cord-311353-ozqfsuh8	70	3	no	no	DT
cord-311353-ozqfsuh8	70	4	specific	specific	JJ
cord-311353-ozqfsuh8	70	5	pharmacological	pharmacological	JJ
cord-311353-ozqfsuh8	70	6	interventions	intervention	NNS
cord-311353-ozqfsuh8	70	7	discovered	discover	VBN
cord-311353-ozqfsuh8	70	8	for	for	IN
cord-311353-ozqfsuh8	70	9	treatment	treatment	NN
cord-311353-ozqfsuh8	70	10	of	of	IN
cord-311353-ozqfsuh8	70	11	COVID-19	covid-19	JJ
cord-311353-ozqfsuh8	70	12	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	70	13	so	so	RB
cord-311353-ozqfsuh8	70	14	far	far	RB
cord-311353-ozqfsuh8	70	15	.	.	.
cord-311353-ozqfsuh8	71	1	The	the	DT
cord-311353-ozqfsuh8	71	2	World	World	NNP
cord-311353-ozqfsuh8	71	3	Health	Health	NNP
cord-311353-ozqfsuh8	71	4	Organization	Organization	NNP
cord-311353-ozqfsuh8	71	5	recommended	recommend	VBD
cord-311353-ozqfsuh8	71	6	that	that	IN
cord-311353-ozqfsuh8	71	7	potential	potential	JJ
cord-311353-ozqfsuh8	71	8	antiviral	antiviral	JJ
cord-311353-ozqfsuh8	71	9	medicines	medicine	NNS
cord-311353-ozqfsuh8	71	10	should	should	MD
cord-311353-ozqfsuh8	71	11	be	be	VB
cord-311353-ozqfsuh8	71	12	developed	develop	VBN
cord-311353-ozqfsuh8	71	13	[	[	-LRB-
cord-311353-ozqfsuh8	71	14	30	30	CD
cord-311353-ozqfsuh8	71	15	]	]	-RRB-
cord-311353-ozqfsuh8	71	16	.	.	.
cord-311353-ozqfsuh8	72	1	However	however	RB
cord-311353-ozqfsuh8	72	2	,	,	,
cord-311353-ozqfsuh8	72	3	the	the	DT
cord-311353-ozqfsuh8	72	4	development	development	NN
cord-311353-ozqfsuh8	72	5	of	of	IN
cord-311353-ozqfsuh8	72	6	potential	potential	JJ
cord-311353-ozqfsuh8	72	7	antiviral	antiviral	JJ
cord-311353-ozqfsuh8	72	8	medicines	medicine	NNS
cord-311353-ozqfsuh8	72	9	may	may	MD
cord-311353-ozqfsuh8	72	10	take	take	VB
cord-311353-ozqfsuh8	72	11	months	month	NNS
cord-311353-ozqfsuh8	72	12	,	,	,
cord-311353-ozqfsuh8	72	13	even	even	RB
cord-311353-ozqfsuh8	72	14	years	year	NNS
cord-311353-ozqfsuh8	72	15	.	.	.
cord-311353-ozqfsuh8	73	1	In	in	IN
cord-311353-ozqfsuh8	73	2	consideration	consideration	NN
cord-311353-ozqfsuh8	73	3	of	of	IN
cord-311353-ozqfsuh8	73	4	these	these	DT
cord-311353-ozqfsuh8	73	5	limitations	limitation	NNS
cord-311353-ozqfsuh8	73	6	,	,	,
cord-311353-ozqfsuh8	73	7	the	the	DT
cord-311353-ozqfsuh8	73	8	application	application	NN
cord-311353-ozqfsuh8	73	9	of	of	IN
cord-311353-ozqfsuh8	73	10	Chinese	chinese	JJ
cord-311353-ozqfsuh8	73	11	medicine	medicine	NN
cord-311353-ozqfsuh8	73	12	could	could	MD
cord-311353-ozqfsuh8	73	13	be	be	VB
cord-311353-ozqfsuh8	73	14	promoted	promote	VBN
cord-311353-ozqfsuh8	73	15	.	.	.
cord-311353-ozqfsuh8	74	1	showed	show	VBD
cord-311353-ozqfsuh8	74	2	that	that	IN
cord-311353-ozqfsuh8	74	3	CM	CM	NNP
cord-311353-ozqfsuh8	74	4	has	have	VBZ
cord-311353-ozqfsuh8	74	5	excellent	excellent	JJ
cord-311353-ozqfsuh8	74	6	outcomes	outcome	NNS
cord-311353-ozqfsuh8	74	7	in	in	IN
cord-311353-ozqfsuh8	74	8	the	the	DT
cord-311353-ozqfsuh8	74	9	treatment	treatment	NN
cord-311353-ozqfsuh8	74	10	of	of	IN
cord-311353-ozqfsuh8	74	11	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	74	12	,	,	,
cord-311353-ozqfsuh8	74	13	bringing	bring	VBG
cord-311353-ozqfsuh8	74	14	new	new	JJ
cord-311353-ozqfsuh8	74	15	hope	hope	NN
cord-311353-ozqfsuh8	74	16	for	for	IN
cord-311353-ozqfsuh8	74	17	the	the	DT
cord-311353-ozqfsuh8	74	18	control	control	NN
cord-311353-ozqfsuh8	74	19	of	of	IN
cord-311353-ozqfsuh8	74	20	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	74	21	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	74	22	[	[	-LRB-
cord-311353-ozqfsuh8	74	23	9	9	CD
cord-311353-ozqfsuh8	74	24	]	]	-RRB-
cord-311353-ozqfsuh8	74	25	[	[	-LRB-
cord-311353-ozqfsuh8	74	26	10	10	CD
cord-311353-ozqfsuh8	74	27	]	]	-RRB-
cord-311353-ozqfsuh8	74	28	[	[	-LRB-
cord-311353-ozqfsuh8	74	29	11	11	CD
cord-311353-ozqfsuh8	74	30	]	]	-RRB-
cord-311353-ozqfsuh8	74	31	[	[	-LRB-
cord-311353-ozqfsuh8	74	32	12	12	CD
cord-311353-ozqfsuh8	74	33	]	]	-RRB-
cord-311353-ozqfsuh8	74	34	[	[	-LRB-
cord-311353-ozqfsuh8	74	35	13	13	CD
cord-311353-ozqfsuh8	74	36	]	]	-RRB-
cord-311353-ozqfsuh8	74	37	[	[	-LRB-
cord-311353-ozqfsuh8	74	38	14	14	CD
cord-311353-ozqfsuh8	74	39	]	]	-RRB-
cord-311353-ozqfsuh8	74	40	[	[	-LRB-
cord-311353-ozqfsuh8	74	41	15	15	CD
cord-311353-ozqfsuh8	74	42	]	]	-RRB-
cord-311353-ozqfsuh8	74	43	.	.	.
cord-311353-ozqfsuh8	75	1	The	the	DT
cord-311353-ozqfsuh8	75	2	results	result	NNS
cord-311353-ozqfsuh8	75	3	of	of	IN
cord-311353-ozqfsuh8	75	4	this	this	DT
cord-311353-ozqfsuh8	75	5	meta	meta	JJ
cord-311353-ozqfsuh8	75	6	-	-	HYPH
cord-311353-ozqfsuh8	75	7	analysis	analysis	NN
cord-311353-ozqfsuh8	75	8	are	be	VBP
cord-311353-ozqfsuh8	75	9	encouraging	encouraging	JJ
cord-311353-ozqfsuh8	75	10	.	.	.
cord-311353-ozqfsuh8	76	1	In	in	IN
cord-311353-ozqfsuh8	76	2	terms	term	NNS
cord-311353-ozqfsuh8	76	3	of	of	IN
cord-311353-ozqfsuh8	76	4	clinical	clinical	JJ
cord-311353-ozqfsuh8	76	5	effective	effective	JJ
cord-311353-ozqfsuh8	76	6	rate	rate	NN
cord-311353-ozqfsuh8	76	7	,	,	,
cord-311353-ozqfsuh8	76	8	viral	viral	JJ
cord-311353-ozqfsuh8	76	9	nucleic	nucleic	JJ
cord-311353-ozqfsuh8	76	10	acid	acid	NN
cord-311353-ozqfsuh8	76	11	negative	negative	JJ
cord-311353-ozqfsuh8	76	12	conversion	conversion	NN
cord-311353-ozqfsuh8	76	13	rate	rate	NN
cord-311353-ozqfsuh8	76	14	,	,	,
cord-311353-ozqfsuh8	76	15	remission	remission	NN
cord-311353-ozqfsuh8	76	16	rate	rate	NN
cord-311353-ozqfsuh8	76	17	of	of	IN
cord-311353-ozqfsuh8	76	18	pulmonary	pulmonary	JJ
cord-311353-ozqfsuh8	76	19	inflammation	inflammation	NN
cord-311353-ozqfsuh8	76	20	,	,	,
cord-311353-ozqfsuh8	76	21	and	and	CC
cord-311353-ozqfsuh8	76	22	biochemical	biochemical	JJ
cord-311353-ozqfsuh8	76	23	markers	marker	NNS
cord-311353-ozqfsuh8	76	24	,	,	,
cord-311353-ozqfsuh8	76	25	CM	CM	NNP
cord-311353-ozqfsuh8	76	26	exhibited	exhibit	VBD
cord-311353-ozqfsuh8	76	27	superior	superior	JJ
cord-311353-ozqfsuh8	76	28	performance	performance	NN
cord-311353-ozqfsuh8	76	29	.	.	.
cord-311353-ozqfsuh8	77	1	Meanwhile	meanwhile	RB
cord-311353-ozqfsuh8	77	2	,	,	,
cord-311353-ozqfsuh8	77	3	CM	CM	NNP
cord-311353-ozqfsuh8	77	4	has	have	VBZ
cord-311353-ozqfsuh8	77	5	therapeutic	therapeutic	JJ
cord-311353-ozqfsuh8	77	6	safety	safety	NN
cord-311353-ozqfsuh8	77	7	.	.	.
cord-311353-ozqfsuh8	78	1	As	as	IN
cord-311353-ozqfsuh8	78	2	the	the	DT
cord-311353-ozqfsuh8	78	3	first	first	JJ
cord-311353-ozqfsuh8	78	4	meta	meta	JJ
cord-311353-ozqfsuh8	78	5	-	-	HYPH
cord-311353-ozqfsuh8	78	6	analysis	analysis	NN
cord-311353-ozqfsuh8	78	7	evaluating	evaluate	VBG
cord-311353-ozqfsuh8	78	8	the	the	DT
cord-311353-ozqfsuh8	78	9	efficacy	efficacy	NN
cord-311353-ozqfsuh8	78	10	and	and	CC
cord-311353-ozqfsuh8	78	11	safety	safety	NN
cord-311353-ozqfsuh8	78	12	of	of	IN
cord-311353-ozqfsuh8	78	13	CM	cm	NN
cord-311353-ozqfsuh8	78	14	for	for	IN
cord-311353-ozqfsuh8	78	15	the	the	DT
cord-311353-ozqfsuh8	78	16	treatment	treatment	NN
cord-311353-ozqfsuh8	78	17	of	of	IN
cord-311353-ozqfsuh8	78	18	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	78	19	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	78	20	,	,	,
cord-311353-ozqfsuh8	78	21	the	the	DT
cord-311353-ozqfsuh8	78	22	wide	wide	JJ
cord-311353-ozqfsuh8	78	23	extent	extent	NN
cord-311353-ozqfsuh8	78	24	of	of	IN
cord-311353-ozqfsuh8	78	25	literature	literature	NN
cord-311353-ozqfsuh8	78	26	screening	screening	NN
cord-311353-ozqfsuh8	78	27	and	and	CC
cord-311353-ozqfsuh8	78	28	the	the	DT
cord-311353-ozqfsuh8	78	29	introduction	introduction	NN
cord-311353-ozqfsuh8	78	30	of	of	IN
cord-311353-ozqfsuh8	78	31	statistical	statistical	JJ
cord-311353-ozqfsuh8	78	32	analysis	analysis	NN
cord-311353-ozqfsuh8	78	33	methods	method	NNS
cord-311353-ozqfsuh8	78	34	have	have	VBP
cord-311353-ozqfsuh8	78	35	ensured	ensure	VBN
cord-311353-ozqfsuh8	78	36	the	the	DT
cord-311353-ozqfsuh8	78	37	validity	validity	NN
cord-311353-ozqfsuh8	78	38	of	of	IN
cord-311353-ozqfsuh8	78	39	this	this	DT
cord-311353-ozqfsuh8	78	40	review	review	NN
cord-311353-ozqfsuh8	78	41	,	,	,
cord-311353-ozqfsuh8	78	42	as	as	RB
cord-311353-ozqfsuh8	78	43	well	well	RB
cord-311353-ozqfsuh8	78	44	as	as	IN
cord-311353-ozqfsuh8	78	45	providing	provide	VBG
cord-311353-ozqfsuh8	78	46	a	a	DT
cord-311353-ozqfsuh8	78	47	rational	rational	JJ
cord-311353-ozqfsuh8	78	48	conclusion	conclusion	NN
cord-311353-ozqfsuh8	78	49	.	.	.
cord-311353-ozqfsuh8	79	1	It	-PRON-	PRP
cord-311353-ozqfsuh8	79	2	is	be	VBZ
cord-311353-ozqfsuh8	79	3	critical	critical	JJ
cord-311353-ozqfsuh8	79	4	for	for	IN
cord-311353-ozqfsuh8	79	5	clinicians	clinician	NNS
cord-311353-ozqfsuh8	79	6	to	to	TO
cord-311353-ozqfsuh8	79	7	accurately	accurately	RB
cord-311353-ozqfsuh8	79	8	determine	determine	VB
cord-311353-ozqfsuh8	79	9	the	the	DT
cord-311353-ozqfsuh8	79	10	severity	severity	NN
cord-311353-ozqfsuh8	79	11	of	of	IN
cord-311353-ozqfsuh8	79	12	a	a	DT
cord-311353-ozqfsuh8	79	13	patients	patient	NNS
cord-311353-ozqfsuh8	79	14	condition	condition	NN
cord-311353-ozqfsuh8	79	15	.	.	.
cord-311353-ozqfsuh8	80	1	At	at	IN
cord-311353-ozqfsuh8	80	2	the	the	DT
cord-311353-ozqfsuh8	80	3	same	same	JJ
cord-311353-ozqfsuh8	80	4	time	time	NN
cord-311353-ozqfsuh8	80	5	,	,	,
cord-311353-ozqfsuh8	80	6	clinicians	clinician	NNS
cord-311353-ozqfsuh8	80	7	follow	follow	VBP
cord-311353-ozqfsuh8	80	8	the	the	DT
cord-311353-ozqfsuh8	80	9	theory	theory	NN
cord-311353-ozqfsuh8	80	10	of	of	IN
cord-311353-ozqfsuh8	80	11	Chinese	chinese	JJ
cord-311353-ozqfsuh8	80	12	medicine	medicine	NN
cord-311353-ozqfsuh8	80	13	,	,	,
cord-311353-ozqfsuh8	80	14	and	and	CC
cord-311353-ozqfsuh8	80	15	determine	determine	VB
cord-311353-ozqfsuh8	80	16	the	the	DT
cord-311353-ozqfsuh8	80	17	appropriate	appropriate	JJ
cord-311353-ozqfsuh8	80	18	prescription	prescription	NN
cord-311353-ozqfsuh8	80	19	to	to	TO
cord-311353-ozqfsuh8	80	20	ensure	ensure	VB
cord-311353-ozqfsuh8	80	21	effective	effective	JJ
cord-311353-ozqfsuh8	80	22	treatment	treatment	NN
cord-311353-ozqfsuh8	80	23	.	.	.
cord-311353-ozqfsuh8	81	1	Especially	especially	RB
cord-311353-ozqfsuh8	81	2	,	,	,
cord-311353-ozqfsuh8	81	3	in	in	IN
cord-311353-ozqfsuh8	81	4	the	the	DT
cord-311353-ozqfsuh8	81	5	absence	absence	NN
cord-311353-ozqfsuh8	81	6	of	of	IN
cord-311353-ozqfsuh8	81	7	Chinese	chinese	JJ
cord-311353-ozqfsuh8	81	8	herbal	herbal	JJ
cord-311353-ozqfsuh8	81	9	medicine	medicine	NN
cord-311353-ozqfsuh8	81	10	,	,	,
cord-311353-ozqfsuh8	81	11	a	a	DT
cord-311353-ozqfsuh8	81	12	variety	variety	NN
cord-311353-ozqfsuh8	81	13	of	of	IN
cord-311353-ozqfsuh8	81	14	A	a	DT
cord-311353-ozqfsuh8	81	15	Review	Review	NNP
cord-311353-ozqfsuh8	81	16	of	of	IN
cord-311353-ozqfsuh8	81	17	Coronavirus	Coronavirus	NNP
cord-311353-ozqfsuh8	81	18	Disease-2019	Disease-2019	NNP
cord-311353-ozqfsuh8	81	19	(	(	-LRB-
cord-311353-ozqfsuh8	81	20	COVID-19	covid-19	VB
cord-311353-ozqfsuh8	81	21	)	)	-RRB-
cord-311353-ozqfsuh8	81	22	The	the	DT
cord-311353-ozqfsuh8	81	23	transmission	transmission	NN
cord-311353-ozqfsuh8	81	24	and	and	CC
cord-311353-ozqfsuh8	81	25	diagnosis	diagnosis	NN
cord-311353-ozqfsuh8	81	26	of	of	IN
cord-311353-ozqfsuh8	81	27	2019	2019	CD
cord-311353-ozqfsuh8	81	28	novel	novel	JJ
cord-311353-ozqfsuh8	81	29	coronavirus	coronavirus	NN
cord-311353-ozqfsuh8	81	30	infection	infection	NN
cord-311353-ozqfsuh8	81	31	disease	disease	NN
cord-311353-ozqfsuh8	81	32	(	(	-LRB-
cord-311353-ozqfsuh8	81	33	COVID-19	covid-19	VB
cord-311353-ozqfsuh8	81	34	)	)	-RRB-
cord-311353-ozqfsuh8	81	35	:	:	:
cord-311353-ozqfsuh8	81	36	A	a	DT
cord-311353-ozqfsuh8	81	37	Chinese	chinese	JJ
cord-311353-ozqfsuh8	81	38	perspective	perspective	NN
cord-311353-ozqfsuh8	81	39	Clinical	clinical	JJ
cord-311353-ozqfsuh8	81	40	Characteristics	characteristic	NNS
cord-311353-ozqfsuh8	81	41	of	of	IN
cord-311353-ozqfsuh8	81	42	138	138	CD
cord-311353-ozqfsuh8	81	43	Hospitalized	hospitalize	VBN
cord-311353-ozqfsuh8	81	44	Patients	patient	NNS
cord-311353-ozqfsuh8	81	45	With	with	IN
cord-311353-ozqfsuh8	81	46	2019	2019	CD
cord-311353-ozqfsuh8	81	47	Novel	Novel	NNP
cord-311353-ozqfsuh8	81	48	Coronavirus	Coronavirus	NNP
cord-311353-ozqfsuh8	81	49	-	-	HYPH
cord-311353-ozqfsuh8	81	50	Infected	infect	VBN
cord-311353-ozqfsuh8	81	51	Pneumonia	Pneumonia	NNP
cord-311353-ozqfsuh8	81	52	in	in	IN
cord-311353-ozqfsuh8	81	53	Wuhan	Wuhan	NNP
cord-311353-ozqfsuh8	81	54	World	World	NNP
cord-311353-ozqfsuh8	81	55	Health	Health	NNP
cord-311353-ozqfsuh8	81	56	Organization	Organization	NNP
cord-311353-ozqfsuh8	81	57	.	.	.
cord-311353-ozqfsuh8	82	1	WHO	who	WP
cord-311353-ozqfsuh8	82	2	Director	Director	NNP
cord-311353-ozqfsuh8	82	3	-	-	HYPH
cord-311353-ozqfsuh8	82	4	General	General	NNP
cord-311353-ozqfsuh8	82	5	's	's	POS
cord-311353-ozqfsuh8	82	6	statement	statement	NN
cord-311353-ozqfsuh8	82	7	on	on	IN
cord-311353-ozqfsuh8	82	8	IHR	IHR	NNP
cord-311353-ozqfsuh8	82	9	Emergency	Emergency	NNP
cord-311353-ozqfsuh8	82	10	Committee	Committee	NNP
cord-311353-ozqfsuh8	82	11	on	on	IN
cord-311353-ozqfsuh8	82	12	Novel	Novel	NNP
cord-311353-ozqfsuh8	82	13	Coronavirus	Coronavirus	NNP
cord-311353-ozqfsuh8	82	14	National	National	NNP
cord-311353-ozqfsuh8	82	15	Health	Health	NNP
cord-311353-ozqfsuh8	82	16	Commission	Commission	NNP
cord-311353-ozqfsuh8	82	17	of	of	IN
cord-311353-ozqfsuh8	82	18	the	the	DT
cord-311353-ozqfsuh8	82	19	People	People	NNPS
cord-311353-ozqfsuh8	82	20	's	's	POS
cord-311353-ozqfsuh8	82	21	Republic	Republic	NNP
cord-311353-ozqfsuh8	82	22	of	of	IN
cord-311353-ozqfsuh8	82	23	China	China	NNP
cord-311353-ozqfsuh8	82	24	.	.	.
cord-311353-ozqfsuh8	83	1	Pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	83	2	Infected	infect	VBN
cord-311353-ozqfsuh8	83	3	by	by	IN
cord-311353-ozqfsuh8	83	4	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	83	5	included	include	VBN
cord-311353-ozqfsuh8	83	6	in	in	IN
cord-311353-ozqfsuh8	83	7	the	the	DT
cord-311353-ozqfsuh8	83	8	management	management	NN
cord-311353-ozqfsuh8	83	9	of	of	IN
cord-311353-ozqfsuh8	83	10	legal	legal	JJ
cord-311353-ozqfsuh8	83	11	infectious	infectious	JJ
cord-311353-ozqfsuh8	83	12	diseases	disease	NNS
cord-311353-ozqfsuh8	84	1	Updated	update	VBN
cord-311353-ozqfsuh8	84	2	guidance	guidance	NN
cord-311353-ozqfsuh8	84	3	for	for	IN
cord-311353-ozqfsuh8	84	4	trusted	trust	VBN
cord-311353-ozqfsuh8	84	5	systematic	systematic	JJ
cord-311353-ozqfsuh8	84	6	reviews	review	NNS
cord-311353-ozqfsuh8	84	7	:	:	:
cord-311353-ozqfsuh8	84	8	a	a	DT
cord-311353-ozqfsuh8	84	9	new	new	JJ
cord-311353-ozqfsuh8	84	10	edition	edition	NN
cord-311353-ozqfsuh8	84	11	of	of	IN
cord-311353-ozqfsuh8	84	12	the	the	DT
cord-311353-ozqfsuh8	84	13	Cochrane	Cochrane	NNP
cord-311353-ozqfsuh8	84	14	Handbook	Handbook	NNP
cord-311353-ozqfsuh8	84	15	for	for	IN
cord-311353-ozqfsuh8	84	16	Systematic	Systematic	NNP
cord-311353-ozqfsuh8	84	17	Reviews	Reviews	NNPS
cord-311353-ozqfsuh8	84	18	of	of	IN
cord-311353-ozqfsuh8	84	19	Interventions	Interventions	NNPS
cord-311353-ozqfsuh8	84	20	Clinical	Clinical	NNP
cord-311353-ozqfsuh8	84	21	study	study	NN
cord-311353-ozqfsuh8	84	22	on	on	IN
cord-311353-ozqfsuh8	84	23	37	37	CD
cord-311353-ozqfsuh8	84	24	case	case	NN
cord-311353-ozqfsuh8	84	25	of	of	IN
cord-311353-ozqfsuh8	84	26	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	84	27	treated	treat	VBN
cord-311353-ozqfsuh8	84	28	with	with	IN
cord-311353-ozqfsuh8	84	29	integrated	integrate	VBN
cord-311353-ozqfsuh8	84	30	traditional	traditional	JJ
cord-311353-ozqfsuh8	84	31	Chinese	chinese	JJ
cord-311353-ozqfsuh8	84	32	and	and	CC
cord-311353-ozqfsuh8	84	33	Western	Western	NNP
cord-311353-ozqfsuh8	84	34	Medicine	Medicine	NNP
cord-311353-ozqfsuh8	84	35	Multi	multi	JJ
cord-311353-ozqfsuh8	84	36	-	-	JJ
cord-311353-ozqfsuh8	84	37	center	center	JJ
cord-311353-ozqfsuh8	84	38	clinical	clinical	JJ
cord-311353-ozqfsuh8	84	39	Observation	observation	NN
cord-311353-ozqfsuh8	84	40	of	of	IN
cord-311353-ozqfsuh8	84	41	Reyanning	reyanne	VBG
cord-311353-ozqfsuh8	84	42	mixture	mixture	NN
cord-311353-ozqfsuh8	84	43	in	in	IN
cord-311353-ozqfsuh8	84	44	Treatment	Treatment	NNP
cord-311353-ozqfsuh8	84	45	of	of	IN
cord-311353-ozqfsuh8	84	46	Novel	Novel	NNP
cord-311353-ozqfsuh8	84	47	Coronavirus	Coronavirus	NNP
cord-311353-ozqfsuh8	84	48	Pneumonia	Pneumonia	NNP
cord-311353-ozqfsuh8	84	49	Observation	Observation	NNP
cord-311353-ozqfsuh8	84	50	on	on	IN
cord-311353-ozqfsuh8	84	51	clinical	clinical	JJ
cord-311353-ozqfsuh8	84	52	effect	effect	NN
cord-311353-ozqfsuh8	84	53	of	of	IN
cord-311353-ozqfsuh8	84	54	Shufeng	Shufeng	NNP
cord-311353-ozqfsuh8	84	55	Jiedu	Jiedu	NNP
cord-311353-ozqfsuh8	84	56	Capsule	Capsule	NNP
cord-311353-ozqfsuh8	84	57	combined	combine	VBN
cord-311353-ozqfsuh8	84	58	with	with	IN
cord-311353-ozqfsuh8	84	59	Arbidol	Arbidol	NNP
cord-311353-ozqfsuh8	84	60	Hydrochloride	Hydrochloride	NNP
cord-311353-ozqfsuh8	84	61	Capsule	Capsule	NNP
cord-311353-ozqfsuh8	84	62	in	in	IN
cord-311353-ozqfsuh8	84	63	treatment	treatment	NN
cord-311353-ozqfsuh8	84	64	of	of	IN
cord-311353-ozqfsuh8	84	65	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	84	66	Analysis	Analysis	NNP
cord-311353-ozqfsuh8	84	67	of	of	IN
cord-311353-ozqfsuh8	84	68	the	the	DT
cord-311353-ozqfsuh8	84	69	value	value	NN
cord-311353-ozqfsuh8	84	70	of	of	IN
cord-311353-ozqfsuh8	84	71	Shufeng	Shufeng	NNP
cord-311353-ozqfsuh8	84	72	Jiedu	Jiedu	NNP
cord-311353-ozqfsuh8	84	73	capsules	capsule	NNS
cord-311353-ozqfsuh8	84	74	combined	combine	VBN
cord-311353-ozqfsuh8	84	75	with	with	IN
cord-311353-ozqfsuh8	84	76	Abidol	Abidol	NNP
cord-311353-ozqfsuh8	84	77	in	in	IN
cord-311353-ozqfsuh8	84	78	the	the	DT
cord-311353-ozqfsuh8	84	79	treatment	treatment	NN
cord-311353-ozqfsuh8	84	80	of	of	IN
cord-311353-ozqfsuh8	84	81	mild	mild	JJ
cord-311353-ozqfsuh8	84	82	novel	novel	JJ
cord-311353-ozqfsuh8	84	83	coronavirus	coronavirus	NN
cord-311353-ozqfsuh8	84	84	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	84	85	Treatment	Treatment	NNP
cord-311353-ozqfsuh8	84	86	of	of	IN
cord-311353-ozqfsuh8	84	87	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	84	88	by	by	IN
cord-311353-ozqfsuh8	84	89	Pneumonia	Pneumonia	NNP
cord-311353-ozqfsuh8	84	90	No.1	No.1	NNP
cord-311353-ozqfsuh8	84	91	Prescription	Prescription	NNP
cord-311353-ozqfsuh8	84	92	and	and	CC
cord-311353-ozqfsuh8	84	93	Pneumonia	Pneumonia	NNP
cord-311353-ozqfsuh8	84	94	No.2	No.2	NNP
cord-311353-ozqfsuh8	85	1	Prescription	Prescription	NNP
cord-311353-ozqfsuh8	85	2	Clinical	clinical	JJ
cord-311353-ozqfsuh8	85	3	Observation	Observation	NNP
cord-311353-ozqfsuh8	85	4	of	of	IN
cord-311353-ozqfsuh8	85	5	Jinhua	Jinhua	NNP
cord-311353-ozqfsuh8	85	6	Qinggan	Qinggan	NNP
cord-311353-ozqfsuh8	85	7	Granule	Granule	NNP
cord-311353-ozqfsuh8	85	8	in	in	IN
cord-311353-ozqfsuh8	85	9	Treating	treat	VBG
cord-311353-ozqfsuh8	85	10	Pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	85	11	Infected	infect	VBN
cord-311353-ozqfsuh8	85	12	by	by	IN
cord-311353-ozqfsuh8	85	13	Novel	Novel	NNP
cord-311353-ozqfsuh8	85	14	Coronavirus	Coronavirus	NNP
cord-311353-ozqfsuh8	85	15	Guiding	guide	VBG
cord-311353-ozqfsuh8	85	16	principles	principle	NNS
cord-311353-ozqfsuh8	85	17	for	for	IN
cord-311353-ozqfsuh8	85	18	clinical	clinical	JJ
cord-311353-ozqfsuh8	85	19	research	research	NN
cord-311353-ozqfsuh8	85	20	of	of	IN
cord-311353-ozqfsuh8	85	21	new	new	JJ
cord-311353-ozqfsuh8	85	22	Chinese	chinese	JJ
cord-311353-ozqfsuh8	85	23	medicines	medicine	NNS
cord-311353-ozqfsuh8	85	24	.	.	.
cord-311353-ozqfsuh8	86	1	1	1	LS
cord-311353-ozqfsuh8	86	2	th	th	CD
cord-311353-ozqfsuh8	86	3	ed	ed	NN
cord-311353-ozqfsuh8	86	4	.	.	.
cord-311353-ozqfsuh8	87	1	Beijing	Beijing	NNP
cord-311353-ozqfsuh8	87	2	,	,	,
cord-311353-ozqfsuh8	87	3	China	China	NNP
cord-311353-ozqfsuh8	87	4	:	:	:
cord-311353-ozqfsuh8	87	5	China	China	NNP
cord-311353-ozqfsuh8	87	6	Medical	Medical	NNP
cord-311353-ozqfsuh8	87	7	Science	Science	NNP
cord-311353-ozqfsuh8	87	8	and	and	CC
cord-311353-ozqfsuh8	87	9	Technology	Technology	NNP
cord-311353-ozqfsuh8	87	10	Press	Press	NNP
cord-311353-ozqfsuh8	87	11	Use	Use	NNP
cord-311353-ozqfsuh8	87	12	of	of	IN
cord-311353-ozqfsuh8	87	13	chest	chest	NN
cord-311353-ozqfsuh8	87	14	CT	CT	NNP
cord-311353-ozqfsuh8	87	15	in	in	IN
cord-311353-ozqfsuh8	87	16	combination	combination	NN
cord-311353-ozqfsuh8	87	17	with	with	IN
cord-311353-ozqfsuh8	87	18	negative	negative	JJ
cord-311353-ozqfsuh8	87	19	RT	RT	NNP
cord-311353-ozqfsuh8	87	20	-	-	HYPH
cord-311353-ozqfsuh8	87	21	PCR	PCR	NNP
cord-311353-ozqfsuh8	87	22	assay	assay	NN
cord-311353-ozqfsuh8	87	23	for	for	IN
cord-311353-ozqfsuh8	87	24	the	the	DT
cord-311353-ozqfsuh8	87	25	2019	2019	CD
cord-311353-ozqfsuh8	87	26	novel	novel	NN
cord-311353-ozqfsuh8	87	27	coronavirus	coronavirus	NN
cord-311353-ozqfsuh8	87	28	but	but	CC
cord-311353-ozqfsuh8	87	29	high	high	JJ
cord-311353-ozqfsuh8	87	30	clinical	clinical	JJ
cord-311353-ozqfsuh8	87	31	suspicion	suspicion	NN
cord-311353-ozqfsuh8	87	32	Correlation	correlation	NN
cord-311353-ozqfsuh8	87	33	of	of	IN
cord-311353-ozqfsuh8	87	34	Chest	Chest	NNP
cord-311353-ozqfsuh8	87	35	CT	CT	NNP
cord-311353-ozqfsuh8	87	36	and	and	CC
cord-311353-ozqfsuh8	87	37	RT	RT	NNP
cord-311353-ozqfsuh8	87	38	-	-	HYPH
cord-311353-ozqfsuh8	87	39	PCR	PCR	NNP
cord-311353-ozqfsuh8	87	40	Testing	Testing	NNP
cord-311353-ozqfsuh8	87	41	in	in	IN
cord-311353-ozqfsuh8	87	42	Coronavirus	Coronavirus	NNP
cord-311353-ozqfsuh8	87	43	Disease	Disease	NNP
cord-311353-ozqfsuh8	87	44	2019	2019	CD
cord-311353-ozqfsuh8	87	45	(	(	-LRB-
cord-311353-ozqfsuh8	87	46	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	87	47	)	)	-RRB-
cord-311353-ozqfsuh8	87	48	in	in	IN
cord-311353-ozqfsuh8	87	49	China	China	NNP
cord-311353-ozqfsuh8	87	50	:	:	:
cord-311353-ozqfsuh8	87	51	A	a	DT
cord-311353-ozqfsuh8	87	52	Report	report	NN
cord-311353-ozqfsuh8	87	53	of	of	IN
cord-311353-ozqfsuh8	87	54	1014	1014	CD
cord-311353-ozqfsuh8	87	55	Cases	case	NNS
cord-311353-ozqfsuh8	88	1	A	a	DT
cord-311353-ozqfsuh8	88	2	novel	novel	JJ
cord-311353-ozqfsuh8	88	3	coronavirus	coronavirus	NN
cord-311353-ozqfsuh8	88	4	from	from	IN
cord-311353-ozqfsuh8	88	5	patients	patient	NNS
cord-311353-ozqfsuh8	88	6	with	with	IN
cord-311353-ozqfsuh8	88	7	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	88	8	in	in	IN
cord-311353-ozqfsuh8	88	9	China	China	NNP
cord-311353-ozqfsuh8	88	10	Genomic	Genomic	NNP
cord-311353-ozqfsuh8	88	11	characterisation	characterisation	NN
cord-311353-ozqfsuh8	88	12	and	and	CC
cord-311353-ozqfsuh8	88	13	epidemiology	epidemiology	NN
cord-311353-ozqfsuh8	88	14	of	of	IN
cord-311353-ozqfsuh8	88	15	2019	2019	CD
cord-311353-ozqfsuh8	88	16	novel	novel	JJ
cord-311353-ozqfsuh8	88	17	coronavirus	coronavirus	NN
cord-311353-ozqfsuh8	88	18	:	:	:
cord-311353-ozqfsuh8	88	19	implications	implication	NNS
cord-311353-ozqfsuh8	88	20	for	for	IN
cord-311353-ozqfsuh8	88	21	virus	virus	NN
cord-311353-ozqfsuh8	88	22	origins	origin	NNS
cord-311353-ozqfsuh8	88	23	and	and	CC
cord-311353-ozqfsuh8	88	24	receptor	receptor	NN
cord-311353-ozqfsuh8	88	25	binding	bind	VBG
cord-311353-ozqfsuh8	88	26	World	World	NNP
cord-311353-ozqfsuh8	88	27	Health	Health	NNP
cord-311353-ozqfsuh8	88	28	Organization	Organization	NNP
cord-311353-ozqfsuh8	88	29	Chest	Chest	NNP
cord-311353-ozqfsuh8	88	30	CT	CT	NNP
cord-311353-ozqfsuh8	88	31	for	for	IN
cord-311353-ozqfsuh8	88	32	typical	typical	JJ
cord-311353-ozqfsuh8	88	33	2019-nCoV	2019-ncov	CD
cord-311353-ozqfsuh8	88	34	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	88	35	:	:	:
cord-311353-ozqfsuh8	88	36	relationship	relationship	NN
cord-311353-ozqfsuh8	88	37	to	to	IN
cord-311353-ozqfsuh8	88	38	negative	negative	JJ
cord-311353-ozqfsuh8	88	39	RT	RT	NNP
cord-311353-ozqfsuh8	88	40	-	-	HYPH
cord-311353-ozqfsuh8	88	41	PCR	PCR	NNP
cord-311353-ozqfsuh8	88	42	testing	test	VBG
cord-311353-ozqfsuh8	88	43	A	a	DT
cord-311353-ozqfsuh8	88	44	rapid	rapid	JJ
cord-311353-ozqfsuh8	88	45	advice	advice	NN
cord-311353-ozqfsuh8	88	46	guideline	guideline	NN
cord-311353-ozqfsuh8	88	47	for	for	IN
cord-311353-ozqfsuh8	88	48	the	the	DT
cord-311353-ozqfsuh8	88	49	diagnosis	diagnosis	NN
cord-311353-ozqfsuh8	88	50	and	and	CC
cord-311353-ozqfsuh8	88	51	treatment	treatment	NN
cord-311353-ozqfsuh8	88	52	of	of	IN
cord-311353-ozqfsuh8	88	53	2019	2019	CD
cord-311353-ozqfsuh8	88	54	novel	novel	JJ
cord-311353-ozqfsuh8	88	55	coronavirus	coronavirus	NN
cord-311353-ozqfsuh8	88	56	(	(	-LRB-
cord-311353-ozqfsuh8	88	57	2019-nCoV	2019-ncov	CD
cord-311353-ozqfsuh8	88	58	)	)	-RRB-
cord-311353-ozqfsuh8	88	59	infected	infect	VBN
cord-311353-ozqfsuh8	88	60	pneumonia	pneumonia	NN
cord-311353-ozqfsuh8	88	61	(	(	-LRB-
cord-311353-ozqfsuh8	88	62	standard	standard	JJ
cord-311353-ozqfsuh8	88	63	version	version	NN
cord-311353-ozqfsuh8	88	64	)	)	-RRB-
cord-311353-ozqfsuh8	89	1	Clinical	clinical	JJ
cord-311353-ozqfsuh8	89	2	,	,	,
cord-311353-ozqfsuh8	89	3	laboratory	laboratory	NN
cord-311353-ozqfsuh8	89	4	and	and	CC
cord-311353-ozqfsuh8	89	5	imaging	imaging	NN
cord-311353-ozqfsuh8	89	6	features	feature	NNS
cord-311353-ozqfsuh8	89	7	of	of	IN
cord-311353-ozqfsuh8	89	8	COVID-19	covid-19	NN
cord-311353-ozqfsuh8	89	9	:	:	:
cord-311353-ozqfsuh8	89	10	A	a	DT
cord-311353-ozqfsuh8	89	11	systematic	systematic	JJ
cord-311353-ozqfsuh8	89	12	review	review	NN
cord-311353-ozqfsuh8	89	13	and	and	CC
cord-311353-ozqfsuh8	89	14	meta	meta	NNP
cord-311353-ozqfsuh8	89	15	-	-	HYPH
cord-311353-ozqfsuh8	89	16	analysis	analysis	NN
cord-311353-ozqfsuh8	89	17	Characteristics	characteristic	NNS
cord-311353-ozqfsuh8	89	18	of	of	IN
cord-311353-ozqfsuh8	89	19	peripheral	peripheral	JJ
cord-311353-ozqfsuh8	89	20	blood	blood	NN
cord-311353-ozqfsuh8	89	21	leukocyte	leukocyte	NN
cord-311353-ozqfsuh8	89	22	differential	differential	NN
cord-311353-ozqfsuh8	89	23	counts	count	NNS
cord-311353-ozqfsuh8	89	24	in	in	IN
cord-311353-ozqfsuh8	89	25	patients	patient	NNS
cord-311353-ozqfsuh8	89	26	with	with	IN
cord-311353-ozqfsuh8	89	27	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	89	28	Clinical	clinical	JJ
cord-311353-ozqfsuh8	89	29	and	and	CC
cord-311353-ozqfsuh8	89	30	immunologic	immunologic	JJ
cord-311353-ozqfsuh8	89	31	features	feature	NNS
cord-311353-ozqfsuh8	89	32	in	in	IN
cord-311353-ozqfsuh8	89	33	severe	severe	JJ
cord-311353-ozqfsuh8	89	34	and	and	CC
cord-311353-ozqfsuh8	89	35	moderate	moderate	JJ
cord-311353-ozqfsuh8	89	36	Coronavirus	Coronavirus	NNP
cord-311353-ozqfsuh8	89	37	Disease	Disease	NNP
cord-311353-ozqfsuh8	89	38	Anti	Anti	NNP
cord-311353-ozqfsuh8	89	39	COVID-19	COVID-19	NNP
cord-311353-ozqfsuh8	89	40	Drugs	drug	NNS
cord-311353-ozqfsuh8	90	1	:	:	:
cord-311353-ozqfsuh8	90	2	Need	need	VB
cord-311353-ozqfsuh8	90	3	for	for	IN
cord-311353-ozqfsuh8	90	4	More	More	JJR
cord-311353-ozqfsuh8	90	5	Clinical	clinical	JJ
cord-311353-ozqfsuh8	90	6	Evidence	Evidence	NNP
cord-311353-ozqfsuh8	90	7	and	and	CC
cord-311353-ozqfsuh8	90	8	Global	Global	NNP
cord-311353-ozqfsuh8	90	9	Action	Action	NNP